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I.  General Information 
 
All manipulations of air‐sensitive materials were carried out in oven-dried glassware 
using standard Schlenk or glovebox techniques under an N2 atmosphere.  Unless 
otherwise noted, chemicals were purchased from commercial suppliers and used as 
received.  CH2Cl2, THF, and toluene were purified and dried using a solvent-purification 
system that contained activated alumina.  Indoline (Aldrich), NEt3 (EMD), SOCl2 (Alfa), 
and SO2Cl2 (Acros) were distilled prior to use.  Carbazole (Aldrich) and 3-methylindole 
(Aldrich) were recrystallized.  Ligand (S)-L* was purchased from Strem (>99.9% ee) and 
used without further purification.  Ligand (R)-L* was purchased from Strem (>98.6% ee) 
and was purified on preparative HPLC in the P-oxide form using a Daicel CHIRALPAK
®
 
AD column (80% i-PrOH/hexanes, 10.0 mL/min; (S)-L*-oxide: 8.6 min, (R)-L*-oxide: 
24.6 min).  The enantiopure ligand (>99.9% ee) was then obtained by reduction in 





C NMR data were collected on a Bruker 400 MHz or a Varian 500 MHz 
spectrometer at ambient temperature unless otherwise noted.  HPLC analyses were 
carried out on an Agilent 1100 Series system, using Daicel CHIRALCEL® columns or 
Daicel CHIRALPAK
®
 columns (internal diameter 4.6 mm, column length 250 mm, 
particle size 5 µm).  ATR-IR measurements were carried out on a Thermo Scientific 
Nicolet iS5 FT-IR spectrometer equipped with an iD5 ATR accessory.  Blue LED lamps 






II.  Preparation of Electrophiles 
 




Representative procedure A for the synthesis of -chloro amides: This is based 
on previously published procedures (31, 32).  The carboxylic acid (25 mmol) was 
dissolved in SOCl2 (7.25 mL, 100 mmol), and the resulting solution was heated at reflux 
at 80 °C for 30 min with vigorous stirring (CaCl2 drying tube).  The mixture was allowed 
to cool to r.t., and then N-chlorosuccinimide (8.34 g, 63 mmol), SOCl2 (5 mL), and HCl 
(concentrated; 4 drops) were added.  The resulting mixture was heated at 90 °C for 2.5 h.  
The mixture was then allowed to cool to r.t., the precipitate was removed by filtration, 
and the solvent was removed by evaporation.  The resulting liquid residue was distilled 
into an ice-cooled flask. 
Next, triethylamine (4.2 mL, 30 mmol) and the -chloro acid chloride were added 
dropwise to a solution of a secondary amine (20 mmol) in CH2Cl2 (100 mL) at 0 °C.  The 
stirring was continued at 0 °C for 15 min and then at r.t. for 3 h.  Next, an aqueous 
solution of HCl (1 M; 50 mL) was added, and the organic layer was separated.  The 
organic phase was washed with water (50 mL) and brine (50 mL), dried over MgSO4, 




2-Chloro-1-(indolin-1-yl)-2-phenylbutan-1-one.  The title compound was prepared 
from 2-phenylbutyric acid and indoline following procedure A.  The product was purified 
by flash chromatography on silica gel (0%  10% Et2O/hexanes), which furnished a 
colorless solid (88% yield over 2 steps).  The enantiomers of the title compound can be 
separated by preparative HPLC on a Daicel CHIRALPAK
®
 AD column (3% i-PrOH/ 
hexanes, 10 mL/min, internal diameter 20 mm, column length 250 mm, particle size 5 
µm). 
1
H NMR (400 MHz, CDCl3) δ 8.32 (d, J = 8.1 Hz, 1H), 7.53 – 7.42 (m, 2H), 7.42 – 
7.28 (m, 3H), 7.28 – 7.19 (m, 1H), 7.14 (dd, J = 7.4, 1.3 Hz, 1H), 7.05 (td, J = 7.4, 1.1 
Hz, 1H), 4.17 (ddd, J = 10.9, 9.6, 6.5 Hz, 1H), 3.06 (ddd, J = 11.0, 9.7, 6.6 Hz, 1H), 2.93 
(ddd, J = 16.1, 9.5, 6.7 Hz, 1H), 2.73 (ddd, J = 15.9, 9.6, 6.6 Hz, 1H), 2.53 (dq, J = 14.5, 
7.3 Hz, 1H), 2.30 (dq, J = 14.5, 7.2 Hz, 1H), 0.86 (t, J = 7.3 Hz, 3H); 
13
C NMR (101 MHz, CDCl3) δ 168.1, 144.0, 139.0, 131.7, 128.7 (2C), 128.1, 127.5, 
126.0 (2C), 124.6, 124.5, 118.3, 76.6, 49.2, 37.8, 28.8, 8.8; 
FT-IR (ATR) 2965, 1656, 1477, 1460, 1445, 1120, 861, 761, 751, 697 cm
-1
; 
HRMS (ESI) m/z (M+H)
+







2-Chloro-2-(4-chlorophenyl)-1-(indolin-1-yl)butan-1-one.  The title compound was 
prepared from 2-(4-chlorophenyl)butanoic acid and indoline following procedure A.  The 
product was purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), 
which furnished a colorless solid (34% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 8.1 Hz, 1H), 7.45 – 7.38 (m, 2H), 7.38 – 
7.32 (m, 2H), 7.27 – 7.19 (m, 1H), 7.15 (dd, J = 7.5, 1.3 Hz, 1H), 7.06 (td, J = 7.4, 1.1 
Hz, 1H), 4.17 (ddd, J = 10.9, 9.6, 6.6 Hz, 1H), 3.10 (ddd, J = 10.9, 9.7, 6.5 Hz, 1H), 2.95 
(ddd, J = 16.0, 9.6, 6.5 Hz, 1H), 2.77 (ddd, J = 15.9, 9.7, 6.6 Hz, 1H), 2.51 (dq, J = 14.5, 
7.2 Hz, 1H), 2.26 (dq, J = 14.5, 7.2 Hz, 1H), 0.86 (t, J = 7.2 Hz, 3H); 
13
C NMR (101 MHz, CDCl3) δ 167.6, 143.8, 137.8, 134.1, 131.6, 129.0, 127.6, 127.4, 
127.3, 124.6, 118.3, 75.9, 49.3, 37.7, 28.8, 8.7; 
FT-IR (ATR) 2973, 2935, 1649, 1477, 1384, 1334, 1092, 1012, 816, 759 cm
-1
; 




2-Chloro-2-cyclopentyl-1-(indolin-1-yl)propan-1-one.  The title compound was 
prepared from 2-cyclopentylpropanoic acid and indoline following procedure A.  The 
product was purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), 
which furnished a colorless solid (32% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 8.27 – 8.21 (m, 1H), 7.26 (tq, J = 6.8, 0.9 Hz, 2H), 
7.11 (td, J = 7.3, 1.1 Hz, 1H), 4.62 (ddd, J = 10.8, 8.8, 6.6 Hz, 1H), 4.50 (ddd, J = 10.8, 
9.0, 7.7 Hz, 1H), 3.27 – 3.10 (m, 2H), 2.99 – 2.86 (m, 1H), 2.01 (ddtt, J = 12.6, 8.9, 6.1, 
3.6 Hz, 1H), 1.85 (s, 3H), 1.81 – 1.47 (m, 7H); 
13
C NMR (101 MHz, CDCl3) δ 169.3, 144.4, 131.6, 127.4, 124.5, 124.4, 118.7, 74.4, 
50.6, 48.4, 29.5, 28.9, 28.1, 26.2, 25.9, 25.4; 




HRMS (ESI) m/z (M+H)
+







2-Chloro-1-(indolin-1-yl)-2,4-dimethylpentan-1-one.  The title compound was 
prepared from 2,4-dimethylpentanoic acid and indoline following procedure A.  The 
product was purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), 
which furnished a colorless solid (37% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 8.30 – 8.17 (m, 1H), 7.26 (ddt, J = 7.9, 6.8, 0.9 Hz, 
2H), 7.11 (td, J = 7.3, 1.1 Hz, 1H), 4.76 (ddd, J = 10.7, 9.2, 6.2 Hz, 1H), 4.31 (ddd, J = 
10.7, 9.3, 7.4 Hz, 1H), 3.30 – 3.08 (m, 2H), 2.25 (dd, J = 14.4, 6.8 Hz, 1H), 2.13 (dd, J = 
14.4, 5.3 Hz, 1H), 1.96 (s, 3H), 1.93 – 1.82 (m, 1H), 1.06 (d, J = 6.7 Hz, 3H), 0.95 (d, J = 
6.7 Hz, 3H); 
13
C NMR (101 MHz, CDCl3) δ 168.9, 144.2, 131.6, 127.5, 124.5, 124.4, 118.6, 70.3, 
50.4, 50.0, 29.8, 29.4, 25.9, 24.6, 23.3; 




 HRMS (ESI) m/z (M+H)
+




2-Chloro-1-(5-methoxyindolin-1-yl)-2-phenylbutan-1-one.  The title compound 
was prepared from 2-phenylbutyric acid and 5-methoxyindoline following procedure A.  
The product was purified by flash chromatography on silica gel (0%  10% 
Et2O/hexanes), which furnished a colorless solid (76% yield over 2 steps). 
1
H NMR (500 MHz, CDCl3) δ 8.23 (d, J = 8.9 Hz, 1H), 7.48 – 7.42 (m, 2H), 7.40 – 
7.34 (m, 2H), 7.35 – 7.28 (m, 1H), 6.76 (ddt, J = 8.9, 2.8, 0.8 Hz, 1H), 6.70 (ddd, J = 2.5, 
1.4, 0.9 Hz, 1H), 4.15 (ddd, J = 11.0, 9.6, 6.4 Hz, 1H), 3.78 (s, 3H), 3.05 (ddd, J = 11.0, 
9.6, 6.6 Hz, 1H), 2.95 – 2.85 (m, 1H), 2.75 – 2.65 (m, 1H), 2.53 (dq, J = 14.5, 7.3 Hz, 
1H), 2.29 (dq, J = 14.4, 7.2 Hz, 1H), 0.86 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 167.5, 156.9, 139.2, 137.6, 133.3, 128.7, 128.0, 126.0, 
118.9, 111.9, 110.8, 76.5, 55.8, 49.3, 37.7, 29.0, 8.8; 




HRMS (ESI) m/z (M+H)
+








2-Chloro-1-(5-chloroindolin-1-yl)-2-phenylbutan-1-one.  The title compound was 
prepared from 2-phenylbutyric acid and 5-chloroindoline following procedure A.  The 
product was purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), 
which furnished a colorless solid (76% yield over 2 steps). 
1
H NMR (500 MHz, CDCl3) δ 8.24 (d, J = 8.7 Hz, 1H), 7.46 – 7.42 (m, 2H), 7.40 – 
7.35 (m, 2H), 7.35 – 7.30 (m, 1H), 7.19 (ddt, J = 8.7, 2.3, 0.8 Hz, 1H), 7.09 (dt, J = 2.2, 
1.1 Hz, 1H), 4.18 (ddd, J = 11.0, 9.7, 6.5 Hz, 1H), 3.06 (ddd, J = 11.0, 9.7, 6.7 Hz, 1H), 
2.96 – 2.86 (m, 1H), 2.76 – 2.66 (m, 1H), 2.51 (dq, J = 14.5, 7.2 Hz, 1H), 2.28 (dq, J = 
14.5, 7.2 Hz, 1H), 0.86 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.2, 142.7, 138.8, 133.5, 129.4, 128.8, 128.2, 127.4, 
125.9, 124.7, 119.1, 76.4, 49.3, 37.7, 28.6, 8.7; 
FT-IR (ATR) 2972, 2931, 1657, 1468, 1374, 1329, 1169, 862, 836, 753, 699 cm
-1
; 




2-Chloro-N-methyl-N,2-diphenylbutanamide.  The title compound was prepared 
from 2-phenylbutyric acid and N-methylaniline following procedure A.  The product was 
purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), which 
furnished a colorless oil (72% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 7.68 – 6.62 (m, 10H), 3.11 (br s, 3H), 2.46 (dt, J = 
14.5, 7.1 Hz, 1H), 2.24 (dq, J = 14.5, 7.2 Hz, 1H), 0.75 (br s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 170.1, 139.8, 128.5, 127.6, 127.1, 125.7, 75.6, 40.9, 
37.9, 8.6; 
FT-IR (ATR) 2975, 2937, 1652, 1594, 1492, 1445, 1363, 1273, 748, 695 cm
-1
; 
HRMS (ESI) m/z (M+H)
+




2-Chloro-1-morpholino-2-phenylbutan-1-one.  The title compound was prepared 
from 2-phenylbutyric acid and morpholine following procedure A.  The product was 
purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), which 
furnished as colorless oil (78% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 7.31 – 7.14 (m, 5H), 3.65 – 2.45 (m, 4H), 3.33 – 3.15 
(m, 2H), 3.00 – 2.75 (m, 2H), 2.26 (dq, J = 14.5, 7.3 Hz, 1H), 2.07 (dq, J = 14.4, 7.2 Hz, 





C NMR (101 MHz, CDCl3) δ 168.9, 139.7, 128.7 (2 C), 128.1, 125.6 (2 C), 74.8, 
66.8, 65.8, 47.8, 43.7, 38.1, 8.8; 








2-Chloro-2-cyclopentyl-N-methoxy-N-methylpropanamide.  The title compound 
was prepared from 2-cyclopentylpropanoic acid and N,O-dimethylhydroxylamine∙HCl 
following procedure A.  The product was purified by flash chromatography on silica gel 
(0%  10% Et2O/hexanes), which furnished a colorless oil (31% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 3.75 (s, 3H), 3.23 (s, 3H), 2.93 – 2.82 (m, 1H), 1.87 – 
1.78 (m, 1H), 1.72 (s, 3H), 1.69 – 1.48 (m, 6H), 1.48 – 1.32 (m, 1H); 
13
C NMR (101 MHz, CDCl3) δ 171.8, 73.1, 60.8, 47.5, 34.4, 28.6, 28.0, 26.1, 25.9, 
24.9; 
FT-IR (ATR) 2950, 2869, 1653, 1456, 1377, 1198, 998, 733, 642 cm
-1
; 
HRMS (ESI) m/z (M+H)
+





Representative procedure B for the synthesis of -chloro amides: This is based on 
previously published procedures (31, 33).  The carboxylic acid (5.0 mmol) was dissolved 
in SOCl2 (1.5 mL, 20 mmol), and the resulting solution was heated at reflux for 30 min 
with vigorous stirring (CaCl2 drying tube).  SO2Cl2 (4.1 g, 50 mmol) was added via a 
dropping funnel over 2 h at 85 °C, and then the mixture was heated at reflux for an 
additional 24 h.  Next, the reaction mixture was allowed to cool to r.t., and the excess 
SOCl2 and SO2Cl2 were removed by distillation. 
Next, triethylamine (1.04 mL, 7.5 mmol) and the α-chloro acid chloride were added 
dropwise to a solution of indoline (560 µL, 5.0 mmol) in CH2Cl2 (20 mL) at 0 °C.  The 
stirring was continued at 0 °C for 15 min and then at r.t. for 3 h.  Next, an aqueous 
solution of HCl (1 M; 20 mL) was added, and the organic layer was separated.  The 
organic phase was washed with water (20 mL) and brine (20 mL), dried over MgSO4, 







2-Chloro-1-(indolin-1-yl)-2,3-diphenylpropan-1-one.  The title compound was 
prepared from 2-chloro-2,3-diphenylpropanoyl chloride following procedure B.  The 
product was purified by flash chromatography on silica gel (0%  10% Et2O/hexanes), 
which furnished a colorless solid (60% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 8.1 Hz, 1H), 7.33 – 7.25 (m, 4H), 7.23 – 
7.16 (m, 2H), 7.17 – 7.12 (m, 2H), 7.11 – 7.03 (m, 3H), 6.74 – 6.66 (m, 2H), 4.15 (ddd, J 
= 10.9, 9.6, 6.3 Hz, 1H), 3.78 (d, J = 14.1 Hz, 1H), 3.62 (d, J = 14.0 Hz, 1H), 3.05 (ddd, J 
= 10.9, 9.6, 6.9 Hz, 1H), 2.94 (ddd, J = 16.2, 9.5, 6.8 Hz, 1H), 2.73 (ddd, J = 15.9, 9.6, 
6.3 Hz, 1H); 
13
C NMR (101 MHz, CDCl3) δ 168.1, 144.0, 138.2, 135.1, 131.9, 131.7, 128.5, 128.3, 
127.6, 127.3, 126.8, 126.4, 124.63, 124.60, 118.4, 75.0, 49.9, 49.3, 28.8; 
FT-IR (ATR) 3026, 1648, 1478, 1384, 1338, 1261, 953, 756, 699, 633 cm
-1
; 
HRMS (ESI) m/z (M+H)
+




2-Chloro-1-(indolin-1-yl)-4-methyl-2-phenylpentan-1-one.  The title compound 
was prepared from 4-methyl-2-phenylpentanoic acid following procedure B.  The product 
was purified by flash chromatography on silica gel (0%  8% Et2O/hexanes), which 
furnished a colorless solid (52% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 8.2 Hz, 1H), 7.53 – 7.44 (m, 2H), 7.40 – 
7.29 (m, 3H), 7.26 – 7.19 (m, 1H), 7.17 – 7.09 (m, 1H), 7.04 (td, J = 7.4, 1.1 Hz, 1H), 
4.16 (ddd, J = 10.8, 9.5, 6.3 Hz, 1H), 3.03 (ddd, J = 10.7, 9.6, 6.8 Hz, 1H), 2.93 (ddd, J = 
16.1, 9.6, 6.7 Hz, 1H), 2.72 (ddd, J = 15.8, 9.6, 6.3 Hz, 1H), 2.50 – 2.37 (m, 1H), 2.33 – 
2.22 (m, 1H), 1.72 (pdd, J = 6.7, 5.4, 4.5 Hz, 1H), 0.90 (d, J = 6.8 Hz, 3H), 0.50 (d, J = 
6.7 Hz, 3H); 
13
C NMR (101 MHz, CDCl3) δ 168.3, 144.1, 139.2, 131.6, 128.8, 128.2, 127.5, 126.1, 
124.6, 124.4, 118.4, 75.9, 52.7, 49.2, 28.8, 24.9, 24.4, 24.3; 
FT-IR (ATR) 2956, 2868, 1656, 1599, 1479, 1387, 1338, 1266, 754, 701 cm
-1
; 
HRMS (ESI) m/z (M+H)
+











Fig. S1.  Picture of the reaction setup, running two reactions in parallel. 
 
General Procedure A and General Procedure B can be used interchangeably. 
 
General Procedure A (glovebox-free).  A stock solution of the catalyst was 
prepared by vigorously stirring CuCl (4.9 mg, 0.050 mmol) and (S)-L* (21.3 mg, 0.060 
mmol) in toluene (10.0 mL) at 60 °C for 30 min under a nitrogen atmosphere.  An oven-
dried 40 mL vial equipped with a magnetic stir bar was capped with a PTFE-lined septum 
cap, cooled under vacuum, and then backfilled with nitrogen.  The carbazole or indole 
nucleophile (0.50 mmol) and LiOt-Bu (60.0 mg, 0.75 mmol) were added to the vial, and 
then the vial was placed under vacuum and refilled with nitrogen (three cycles).  Next, 
toluene (17 mL) was added, and the resulting mixture was stirred for 5 min.  Then, the 
catalyst (1.0 mL of the stock solution) was added, and the reaction mixture was stirred at 
r.t. for 20 min.  The alkyl chloride (0.60 mmol) was added to an oven-dried 4 mL vial, 
the vial was capped, and then it was evacuated and backfilled with nitrogen (three 
cycles).  Toluene (2.0 mL) was added, and the resulting solution was transferred to the 
reaction mixture via syringe.  The reaction mixture was degassed by applying three 
freeze-pump-thaw cycles.  The reaction vial was backfilled with nitrogen, detached from 
the Schlenk line, and the holes in the septum were covered with grease.  The vial was 
placed ~5 cm from two 32 W blue LED lamps, and the reaction mixture was irradiated at 




short plug of silica (eluant: Et2O; monitored by TLC), and the resulting solution was 
concentrated under vacuum and purified by flash chromatography (hexanes/Et2O). 
A second run was performed using (R)-L*. 
General Procedure B (glovebox).  In a nitrogen-filled glovebox, a stock solution of 
the catalyst was prepared by vigorously stirring CuCl (4.9 mg, 0.050 mmol) and (S)-L* 
(21.3 mg, 0.060 mmol) in toluene (10.0 mL) for 30 min; gentle heating by a heat gun 
facilitated the dissolution of the components.  The carbazole or indole nucleophile (0.50 
mmol) and LiOt-Bu (60.0 mg, 0.75 mmol) were added to a 40 mL vial, followed by a stir 
bar and toluene (17 mL).  The mixture was stirred for 5 min, and then the stock solution 
of the catalyst (1.0 mL) was added, and stirring was continued for 20 min.  The alkyl 
chloride (0.60 mmol) was dissolved in toluene (2.0 mL) and added to the reaction 
mixture.  The vial was sealed with a PTFE-lined septum cap, the joint was wrapped with 
electrical tape, and the vial was taken out of the glovebox.  The vial was placed ~5 cm 
from two 32 W blue LED lamps, and the reaction mixture was irradiated at –40 °C for 16 
h under a nitrogen atmosphere.  Next, the mixture was passed through a short plug of 
silica (eluant: Et2O; monitored by TLC), and the resulting solution was concentrated 
under vacuum and purified by flash chromatography (hexanes/Et2O). 





 (S)-2-(Carbazol-9-yl)-1-(indolin-1-yl)-2-phenylbutan-1-one (Fig. 2B, Entry 1).  
The title compound was synthesized according to General Procedure A from carbazole 
(83.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-one (179.9 mg, 
0.60 mmol).  The product was purified by flash chromatography (0%  7% 
Et2O/hexanes).  Colorless solid.  First run: 193 mg (90% yield), 94% ee.  Second run: 196 
mg (91% yield), 93% ee. 
X-ray quality crystals were obtained by slow evaporation of solvent from a saturated 
solution in hexanes of a sample synthesized with (S)-L*. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (5% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 6.2 
min (minor), 7.7 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.37 (dt, J = 8.2, 0.7 Hz, 1H), 8.14 – 8.11 (m, 2H), 
7.60 – 7.56 (m, 2H), 7.36 – 7.31 (m, 3H), 7.27 – 7.18 (m, 7H), 7.10 – 7.02 (m, 2H), 3.76 
(ddd, J = 10.8, 9.3, 4.0 Hz, 1H), 3.24 (dq, J = 14.2, 7.1 Hz, 1H), 3.11 (dt, J = 10.8, 9.3 
Hz, 1H), 2.92 (dq, J = 14.5, 7.3 Hz, 1H), 2.72 – 2.60 (m, 1H), 2.57 (ddd, J = 15.5, 9.2, 
4.0 Hz, 1H), 0.69 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.6, 144.0, 141.3, 137.9, 131.9, 128.8, 128.0, 127.9, 
127.4, 125.6, 124.6, 124.5, 124.3, 120.1, 120.0, 119.1, 113.6, 74.2, 49.3, 32.3, 29.4, 10.5; 




HRMS (ESI) m/z (M+H)
+









(S)-2-(Carbazol-9-yl)-1-(indolin-1-yl)-2,3-diphenylpropan-1-one (Fig. 2B, Entry 
2).  The title compound was synthesized according to General Procedure B from 
carbazole (66.9 mg, 0.40 mmol) and 2-chloro-1-(indolin-1-yl)-2,3-diphenylpropan-1-one 
(173.7 mg, 0.48 mmol).  The product was purified by flash chromatography (0%  10% 
Et2O/hexanes).  Colorless solid.  First run: 149 mg (76% yield), 96% ee.  Second run: 154 
mg (78% yield), 91% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 7.6 
min (minor), 13.9 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.44 (dt, J = 8.2, 0.8 Hz, 1H), 8.11 – 8.03 (m, 2H), 
7.77 – 7.68 (m, 2H), 7.46 – 7.35 (m, 3H), 7.33 – 7.27 (m, 1H), 7.18 (t, J = 7.4 Hz, 2H), 
7.13 – 7.04 (m, 4H), 6.97 (s, 2H), 6.80 (dt, J = 8.7, 4.3 Hz, 1H), 6.69 (d, J = 4.3 Hz, 4H), 
4.80 (d, J = 13.5 Hz, 1H), 4.01 (d, J = 13.5 Hz, 1H), 3.77 (ddd, J = 10.7, 7.8, 5.0 Hz, 1H), 
3.32 (dt, J = 10.7, 9.3 Hz, 1H), 2.59 – 2.46 (m, 2H); 
13
C NMR (126 MHz, CDCl3) δ 167.7, 144.1, 141.0, 136.5, 135.7, 131.8, 131.0, 128.9, 
128.0, 127.8, 127.3, 127.0, 126.4, 124.9, 124.5, 124.3, 124.1, 119.65, 119.56, 119.0, 
113.8, 74.9, 49.5, 42.6, 29.3; 




HRMS (FAB) m/z (M+H)
+
 calcd for C35H29N2O: 493.2280, found: 493.2280; 





(S)-2-(Carbazol-9-yl)-1-(indolin-1-yl)-4-methyl-2-phenylpentan-1-one (Fig. 2B, 
Entry 3).  The title compound was synthesized according to General Procedure B from 
carbazole (66.9 mg, 0.40 mmol) and 2-chloro-1-(indolin-1-yl)-4-methyl-2-phenylpentan-
1-one (157.4 mg, 0.48 mmol).  The product was purified by flash chromatography (0% 
 7% Et2O/hexanes).  Colorless solid.  First run: 150 mg (82% yield), 99% ee.  Second 




The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 0.7 mL/min); retention times for compound obtained using (S)-L*: 6.5 
min (minor), 7.6 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.42 (d, J = 8.1 Hz, 1H), 8.17 (dd, J = 7.5, 2.0 Hz, 
2H), 7.72 – 7.63 (m, 2H), 7.55 – 7.14 (m, 10H), 7.13 – 7.03 (m, 2H), 3.82 (ddd, J = 10.8, 
9.2, 3.4 Hz, 1H), 3.22 (dd, J = 14.2, 3.7 Hz, 1H), 3.05 (q, J = 9.9 Hz, 1H), 2.81 (dd, J = 
14.1, 5.9 Hz, 1H), 2.65 (dt, J = 15.3, 9.5 Hz, 1H), 2.55 (ddd, J = 15.4, 9.1, 3.4 Hz, 1H), 
1.80 (dqd, J = 13.1, 6.6, 3.7 Hz, 1H), 0.92 (d, J = 6.7 Hz, 3H), 0.22 (d, J = 6.6 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.5, 144.0, 140.9, 138.1, 131.8, 128.7, 127.7, 127.6, 
127.3, 125.3, 124.4, 124.3, 124.2, 120.0, 119.8, 119.0, 74.2, 49.4, 47.0, 29.3, 25.3, 25.0, 
23.5; 
FT-IR (ATR) 2955, 1652, 1595, 1489, 1446, 1375, 1313, 1211, 1163, 748, 724 cm
-1
; 
HRMS (FAB) m/z (M+H)
+
 calcd for C32H31N2O: 459.2431, found: 459.2435; 





(S)-2-(Carbazol-9-yl)-2-(4-chlorophenyl)-1-(indolin-1-yl)butan-1-one (Fig. 2B, 
Entry 4).  The title compound was synthesized according to General Procedure A from 
carbazole (83.6 mg, 0.50 mmol) and 2-chloro-2-(4-chlorophenyl)-1-(indolin-1-yl)butan-
1-one (200.5 mg, 0.60 mmol).  The product was purified by flash chromatography (0% 
 7% Et2O/hexanes).  Colorless solid.  First run: 196 mg (84% yield), 95% ee.  Second 
run: 200 mg (86% yield), 90% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 7.4 
min (minor), 9.6 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.40 (dt, J = 8.1, 0.8 Hz, 1H), 8.17 (dd, J = 7.1, 2.7 
Hz, 2H), 7.57 – 7.52 (m, 2H), 7.35 – 7.31 (m, 2H), 7.31 – 7.23 (m, 7H), 7.14 – 7.06 (m, 
2H), 3.85 (ddd, J = 10.6, 9.4, 3.7 Hz, 1H), 3.25 (dq, J = 14.2, 7.1 Hz, 1H), 3.03 – 2.91 
(m, 2H), 2.81 – 2.68 (m, 1H), 2.59 (ddd, J = 15.6, 9.2, 3.7 Hz, 1H), 0.81 (t, J = 7.2 Hz, 
3H); 
13
C NMR (126 MHz, CDCl3) δ 168.2, 143.8, 140.9, 137.2, 133.7, 131.6, 130.0, 128.0, 
127.4, 125.8, 124.6, 124.4, 124.2, 120.12, 120.08, 118.9, 113.3, 73.7, 49.1, 32.2, 29.2, 
10.4; 
FT-IR (ATR) 2957, 1650, 1598, 1476, 1446, 1370, 1209, 1091, 838, 747, 721 cm
-1
; 
HRMS (ESI) m/z (M+H)
+
 calcd for C30H26ClN2O: 465.1728, found: 465.1726; 








(R)-2-(Carbazol-9-yl)-2-cyclopentyl-1-(indolin-1-yl)propan-1-one (Fig. 2B, Entry 
5).  The title compound was synthesized according to General Procedure A from 
carbazole (83.6 mg, 0.50 mmol) and 2-chloro-2-cyclopentyl-1-(indolin-1-yl)propan-1-
one (166.7 mg, 0.60 mmol).  The product was purified by flash chromatography (0%  
7% Et2O/hexanes).  White solid.  First run: 169 mg (83% yield), 97% ee.  Second run: 
172 mg (84% yield), 98% ee. 
X-ray quality crystals were obtained by slow diffusion of pentane into a saturated 
solution in benzene of a sample synthesized with (S)-L*. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 IB column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 6.2 
min (major), 7.0 min (minor). 
1
H NMR (500 MHz, CDCl3) δ 8.51 – 8.45 (m, 1H), 8.21 – 8.08 (m, 2H), 7.94 (d, J = 
8.6 Hz, 1H), 7.61 (d, J = 8.5 Hz, 1H), 7.50 – 7.42 (m, 1H), 7.32 (q, J = 6.3 Hz, 2H), 7.29 
– 7.20 (m, 2H), 7.09 – 7.01 (m, 2H), 3.81 (ddd, J = 10.9, 9.7, 4.0 Hz, 1H), 3.61 – 3.50 
(m, 1H), 2.90 – 2.79 (m, 1H), 2.50 – 2.46 (m, 1H), 2.45 (s, 3H), 2.43 – 2.30 (m, 2H), 1.81 
– 1.63 (m, 3H), 1.48 (d, J = 3.3 Hz, 1H), 1.42 – 1.30 (m, 2H), 0.91 – 0.82 (m, 1H); 
13
C NMR (126 MHz, CDCl3) δ 173.1, 144.0, 140.7, 139.7, 131.2, 127.3, 126.1, 124.3, 
124.1, 123.7, 120.5, 119.7, 119.4, 118.1, 112.5, 111.7, 69.8, 47.7, 47.6, 29.1, 28.9, 27.7, 
26.3, 24.1, 19.9. 
FT-IR (ATR) 2959, 1645, 1595, 1476, 1443, 1391, 1375, 1314, 1222, 747, 726 cm
-1
; 
HRMS (FAB) m/z (M+H)
+
 calcd for C28H29N2O: 409.2280, found: 409.2297; 





(R)-2-(Carbazol-9-yl)-1-(indolin-1-yl)-2,4-dimethylpentan-1-one (Fig. 2B, Entry 
6).  The title compound was synthesized according to General Procedure A from 
carbazole (83.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2,4-dimethylpentan-1-one 
(159.5 mg, 0.60 mmol).  The product was purified by flash chromatography (0%  7% 
Et2O/hexanes).  Colorless solid.  First run: 181 mg (91% yield), 89% ee.  Second run: 179 










The ee was determined by HPLC on a Daicel CHIRALPAK
®
 OD column (5% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 5.3 
min (major), 9.5 min (minor). 
1
H NMR (500 MHz, CDCl3) δ 8.40 (dd, J = 8.2, 0.9 Hz, 1H), 8.16 – 8.02 (m, 2H), 
7.89 (d, J = 8.5 Hz, 1H), 7.53 (d, J = 8.3 Hz, 1H), 7.47 – 7.37 (m, 1H), 7.37 – 7.30 (m, 
1H), 7.29 – 7.17 (m, 3H), 7.05 – 6.96 (m, 2H), 3.54 (d, J = 11.9 Hz, 1H), 2.89 – 2.72 (m, 
2H), 2.50 (ddd, J = 15.0, 9.5, 4.1 Hz, 1H), 2.37 (dd, J = 14.4, 4.2 Hz, 5H), 1.68 (hd, J = 
6.6, 4.2 Hz, 1H), 0.97 (d, J = 6.7 Hz, 3H), 0.27 (d, J = 6.5 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 172.7, 143.9, 140.7, 139.8, 131.1, 127.3, 126.2, 124.3, 
124.1, 123.7, 120.5, 119.9, 119.7, 119.5, 118.1, 111.9, 111.8, 67.8, 47.4, 45.8, 28.9, 25.6, 
24.4, 23.8; 
FT-IR (ATR) 2954, 1640, 1595, 1477, 1454, 1375, 1316, 1220, 1075, 750, 723 cm
-1
; 
HRMS (FAB) m/z (M+H)
+
 calcd for C27H29N2O: 397.2280, found: 397.2270; 





(S)-2-(Carbazol-9-yl)-1-(5-methoxyindolin-1-yl)-2-phenylbutan-1-one (Fig. 2B, 
Entry 7).  The title compound was synthesized according to General Procedure A from 
carbazole (83.6 mg, 0.50 mmol) and 2-chloro-1-(5-methoxyindolin-1-yl)-2-phenylbutan-
1-one (197.9 mg, 0.60 mmol).  The product was purified by flash chromatography (0% 
 15% Et2O/hexanes).  Colorless solid.  First run: 213 mg (94% yield), 92% ee.  Second 
run: 208 mg (90% yield), 92% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (5% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 10.2 
min (minor), 14.1 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.35 (d, J = 8.9 Hz, 1H), 8.21 – 8.13 (m, 2H), 7.66 – 
7.60 (m, 2H), 7.42 – 7.33 (m, 3H), 7.31 – 7.09 (m, 6H), 6.82 (ddd, J = 8.7, 2.1, 1.3 Hz, 
1H), 6.70 (dd, J = 2.6, 1.2 Hz, 1H), 3.82 (s, 4H), 3.30 (dq, J = 14.2, 7.1 Hz, 1H), 3.14 (dt, 
J = 10.8, 9.2 Hz, 1H), 2.95 (dq, J = 14.5, 7.3 Hz, 1H), 2.67 (dtt, J = 15.6, 9.2, 1.1 Hz, 
1H), 2.57 (ddd, J = 15.6, 9.2, 3.9 Hz, 1H), 0.73 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 167.8, 156.9, 141.2, 137.9, 137.4, 133.4, 128.7, 127.9, 
127.7, 125.5, 124.2, 120.0, 119.8, 119.6, 113.6, 111.7, 110.6, 73.9, 55.6, 49.4, 32.1, 29.4, 
10.4; 




HRMS (ESI) m/z (M+H)
+
 calcd for C31H29N2O2: 461.2224, found: 461.2220; 








(S)-2-(Carbazol-9-yl)-1-(5-chloroindolin-1-yl)-2-phenylbutan-1-one (Fig. 2B, 
Entry 8).  The title compound was synthesized according to General Procedure A from 
carbazole (83.6 mg, 0.50 mmol) and 2-chloro-1-(5-chloroindolin-1-yl)-2-phenylbutan-1-
one (200.5 mg, 0.60 mmol).  The product was purified by flash chromatography (0%  
10% Et2O/hexanes).  Colorless solid.  First run: 213 mg (91% yield), 96% ee.  Second 
run: 206 mg (89% yield), 96% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 9.1 
min (minor), 11.6 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.37 (d, J = 8.7 Hz, 1H), 8.21 – 8.14 (m, 2H), 7.66 – 
7.59 (m, 2H), 7.43 – 7.34 (m, 3H), 7.33 – 7.11 (m, 7H), 7.08 (dt, J = 2.3, 1.2 Hz, 1H), 
3.82 (ddd, J = 10.8, 9.4, 4.1 Hz, 1H), 3.29 (dq, J = 14.2, 7.1 Hz, 1H), 3.15 (dt, J = 10.9, 
9.3 Hz, 1H), 2.97 (dq, J = 14.5, 7.3 Hz, 1H), 2.67 (dtt, J = 15.7, 9.3, 1.1 Hz, 1H), 2.58 
(ddd, J = 15.7, 9.3, 4.1 Hz, 1H), 0.75 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.6, 142.5, 141.0, 137.6, 133.7, 129.5, 128.7, 128.0, 
127.9, 127.3, 125.6, 124.5, 124.2, 120.1, 120.0, 119.8, 113.2, 74.0, 49.4, 32.1, 29.0, 10.4; 




HRMS (ESI) m/z (M+H)
+
 calcd for C30H26ClN2O: 465.1728, found: 465.1725; 





(S)-2-(Carbazol-9-yl)-N-methyl-N,2-diphenylbutanamide (Fig. 2B, Entry 9).  The 
title compound was synthesized according to General Procedure A from carbazole (83.6 
mg, 0.50 mmol) and 2-chloro-N-methyl-N,2-diphenylbutanamide (172.7 mg, 0.60 mmol).  
3.0 mL of the stock solution of the catalyst were used (3.0 mol% CuCl).  The product was 
purified by flash chromatography (0%  10% Et2O/hexanes).  Colorless solid.  First run: 
162 mg (78% yield), 94% ee.  Second run: 168 mg (80% yield), 93% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (5% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 6.5 
min (major), 9.6 min (minor). 
1
H NMR (500 MHz, d6-DMSO, 80 °C) δ 8.12 (dd, J = 7.3, 1.6 Hz, 2H), 7.49 – 7.41 
(m, 2H), 7.30 (d, J = 6.8 Hz, 3H), 7.23 – 7.13 (m, 4H), 7.12 – 6.90 (m, 5H), 6.59 (s, 2H), 










C NMR (126 MHz, d6-DMSO, 80 °C) δ 170.5, 144.4, 141.1, 140.5, 129.1, 128.8, 
128.2, 128.1, 127.1, 126.8, 125.6, 124.2, 120.1, 119.7, 113.6, 73.8, 41.3, 32.2, 10.3; 
FT-IR (ATR) 2936, 1651, 1593, 1473, 1445, 1367, 1315, 1213, 750, 723, 698 cm
-1
; 
HRMS (FAB) m/z (M)
+•
 calcd for C29H26N2O: 418.2045, found: 418.2048; 





(S)-2-(Carbazol-9-yl)-1-morpholino-2-phenylbutan-1-one (Fig. 2B, Entry 10).  
The title compound was synthesized according to General Procedure A from carbazole 
(83.6 mg, 0.50 mmol) and 2-chloro-1-morpholino-2-phenylbutan-1-one (160.7 mg, 0.60 
mmol).  The product was purified by flash chromatography (0%  30% Et2O/hexanes).  
Colorless solid.  First run: 145 mg (73% yield), 90% ee.  Second run: 149 mg (75% 
yield), 90% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (3% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 15.4 
min (minor), 22.9 min (major). 
1
H NMR (500 MHz, d6-DMSO, 80 °C) δ 8.20 (dd, J = 7.4, 1.2 Hz, 2H), 7.47 (dd, J = 
7.7, 2.1 Hz, 2H), 7.41 – 7.33 (m, 3H), 7.30 (ddd, J = 8.6, 7.1, 1.4 Hz, 2H), 7.23 (t, J = 7.4 
Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 3.37 – 3.22 (m, 4H), 3.09 – 2.84 (m, 6H), 0.66 (t, J = 
7.2 Hz, 3H); 
13
C NMR (126 MHz, d6-DMSO, 80 °C) δ 168.9, 140.9, 139.9, 128.6, 128.3, 128.1, 
125.9, 124.2, 120.5, 120.2, 113.9, 73.4, 65.6, 45.6, 32.0, 10.4; 




HRMS (ESI) m/z (M+H)
+
 calcd for C26H27N2O2: 399.2067, found: 399.2068; 





(R)-2-(Carbazol-9-yl)-2-cyclopentyl-N-methoxy-N-methylpropanamide (Fig. 2B, 
Entry 11).  The title compound was synthesized according to General Procedure A from 
carbazole (83.6 mg, 0.50 mmol) and 2-chloro-2-cyclopentyl-N-methoxy-N-
methylpropanamide (131.8 mg, 0.60 mmol).  5.0 mL of the stock solution of the catalyst 










7% Et2O/hexanes).  Sticky white solid.  First run: 127 mg (73% yield), 95% ee.  Second 
run: 127 mg (73% yield), 95% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 0.7 mL/min); retention times for compound obtained using (S)-L*: 8.2 
min (minor), 9.1 min (major). 
1
H NMR (500 MHz, d6-DMSO, 80 °C) δ 8.22 – 8.08 (m, 2H), 7.71 (d, J = 8.6 Hz, 
2H), 7.37 (ddd, J = 8.8, 7.2, 1.5 Hz, 2H), 7.19 (t, J = 7.4 Hz, 2H), 3.38 (dt, J = 10.6, 7.5 
Hz, 1H), 2.97 (s, 3H), 2.52 (s, 3H), 2.27 (s, 3H), 2.14 – 2.00 (m, 1H), 1.60 – 1.52 (m, 
3H), 1.43 (dt, J = 15.4, 5.6 Hz, 1H), 1.33 – 1.18 (m, 2H), 0.75 – 0.62 (m, 1H); 
13
C NMR (126 MHz, d6-DMSO, 80 °C) δ 173.5, 140.6, 126.1, 123.6, 120.3, 119.4, 
112.7, 69.0, 59.4, 46.7, 33.9, 28.9, 27.2, 26.1, 24.4, 19.1. 




HRMS (ESI) m/z (M)
+
 calcd for C22H26N2O2: 350.1994, found: 350.1987; 





(S)-2-(3-Ethyl-carbazol-9-yl)-1-(indolin-1-yl)-2-phenylbutan-1-one (Fig. 2C, 
Entry 1).  The title compound was synthesized according to General Procedure A from 
3-ethylcarbazole (97.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-
one (179.9 mg, 0.60 mmol).  The product was purified by flash chromatography (0%  
7% Et2O/hexanes).  Colorless solid.  First run: 215 mg (94% yield), 93% ee.  Second run: 
219 mg (96% yield), 92% ee. 
Gram-scale reaction: A solution of the catalyst was prepared by vigorously stirring 
CuCl (3.0 mg, 30 μmol) and (S)-L* (12.8 mg, 36 μmol) in toluene (7.2 mL) at 60 °C for 
30 min under nitrogen.  An oven-dried 250 mL round-bottom flask equipped with a stir 
bar was capped with a septum, cooled under vacuum, and then backfilled with nitrogen.  
3-Ethylcarbazole (586 mg, 3.0 mmol) and LiOt-Bu (360 mg, 4.5 mmol) were added to 
the flask, which was then placed under vacuum and refilled with nitrogen (three cycles).  
Then, toluene (100 mL) was added, and the mixture was stirred for 5 min.  Next, the 
solution of catalyst was added, with the aid of toluene (0.8 mL), and the resulting mixture 
was stirred at r.t. for 20 min.  2-Chloro-1-(indolin-1-yl)-2-phenylbutan-1-one (1.08 g, 3.6 
mmol) was added to an oven-dried 20 mL vial, the vial was capped, and then it was 
evacuated and backfilled with nitrogen (three cycles).  Toluene (12 mL) was added, and 
the solution was transferred via syringe to the reaction mixture.  The mixture was 
degassed by applying three freeze-pump-thaw cycles.  The reaction vial was backfilled 
with nitrogen and then detached from the Schlenk line, and the holes in the septum were 
covered by grease.  The flask was placed ~5 cm from three 32 W blue LED lamps, and 
the reaction mixture was irradiated at −40 °C for 20 h under a nitrogen atmosphere.  




TLC).  The resulting solution was concentrated under vacuum, and the residue was 
purified by flash chromatography (0%  6% Et2O/hexanes), which furnished 1.29 g 
(94% yield, 94% ee) of a colorless powder. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 7.1 
min (minor), 9.1 min (major). 
1
H NMR (500 MHz, d6-DMSO, 80 °C) δ 8.24 (d, J = 8.2 Hz, 1H), 8.21 – 8.15 (m, 
1H), 8.03 (dd, J = 1.8, 0.9 Hz, 1H), 7.58 – 7.52 (m, 2H), 7.40 – 7.29 (m, 3H), 7.23 – 7.05 
(m, 7H), 7.02 (td, J = 7.4, 1.1 Hz, 1H), 3.65 (ddd, J = 10.8, 9.3, 5.2 Hz, 1H), 3.17  – 3.10 
(m, 1H), 3.07 – 2.98 (m, 2H), 2.75 (q, J = 7.6 Hz, 2H), 2.70 – 2.54 (m, 2H), 1.28 (t, J = 
7.6 Hz, 3H), 0.73 (t, J = 7.2 Hz, 3H). 
13
C NMR (126 MHz, d6-DMSO, 80 °C) δ 169.1, 144.2, 141.4, 139.6, 139.3, 135.7, 
132.1, 128.8, 128.4, 128.2, 127.3, 126.2, 125.8, 124.9, 124.6, 124.3, 124.1, 120.5, 120.0, 
119.2, 118.4, 113.3, 113.2, 74.0, 49.2, 31.8, 29.0, 28.2, 16.1, 10.5; 
FT-IR (ATR) 2960, 1649, 1597, 1477, 1452, 1370, 1213, 875, 748, 717 cm
-1
; 
HRMS (ESI) m/z (M+H)
+
 calcd for C32H31N2O: 459.2431, found: 459.2445; 





(S)-1-(Indolin-1-yl)-2-(3-methoxy-carbazol-9-yl)-2-phenylbutan-1-one (Fig. 2C, 
Entry 2).  The title compound was synthesized according to General Procedure A from 
3-methoxy-carbazole (98.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-
1-one (179.9 mg, 0.60 mmol).  3.0 mL of the stock solution of the catalyst were used (3.0 
mol% CuCl).  The product was purified by flash chromatography (0%  12% 
Et2O/hexanes).  Colorless solid.  First run: 221 mg (96% yield), 90% ee.  Second run: 204 
mg (89% yield), 88% ee. 
The ee was determined by HPLC on a Daicel CHIRALCEL
®
 OD column (2% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 9.2 
min (major), 12.4 min (minor). 
1
H NMR (500 MHz, d6-DMSO, 80 °C) δ 8.24 (d, J = 8.2 Hz, 1H), 8.22 – 8.17 (m, 
1H), 7.76 (d, J = 2.7 Hz, 1H), 7.58 – 7.50 (m, 2H), 7.41 – 7.31 (m, 3H), 7.23 – 7.11 (m, 
5H), 7.09 – 6.98 (m, 2H), 6.87 (dd, J = 9.2, 2.7 Hz, 1H), 3.86 (s, 3H), 3.66 (ddd, J = 10.9, 
9.4, 5.1 Hz, 1H), 3.13 (dt, J = 14.1, 7.2 Hz, 1H), 3.06 – 2.96 (m, 2H), 2.73 – 2.54 (m, 
2H), 0.73 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, d6-DMSO, 80 °C) δ 169.2, 154.2, 144.2, 141.7, 139.3, 135.9, 
132.1, 128.8, 128.4, 128.2, 127.3, 126.0, 125.01, 124.95, 124.7, 124.1, 120.8, 119.7, 
118.4, 114.8, 114.1, 113.3, 104.0, 74.0, 56.2, 49.2, 31.8, 29.0, 10.5; 
FT-IR (ATR) 2935, 1674, 1597, 1477, 1455, 1374, 1320, 1291, 1200, 1173, 1032, 
750, 717, 699 cm
-1
; 
HRMS (ESI) m/z (M+H)
+









(S)-2-(3-Bromo-carbazol-9-yl)-1-(indolin-1-yl)-2-phenylbutan-1-one (Fig. 2C, 
Entry 3).  The title compound was synthesized according to General Procedure A from 
3-bromo-carbazole (123.1 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-
1-one (179.9 mg, 0.60 mmol).  3.0 mL of the stock solution of the catalyst were used (3.0 
mol% CuCl).  The product was purified by flash chromatography (0%  7% 
Et2O/hexanes).  Colorless solid.  First run: 203 mg (80% yield), 93% ee.  Second run: 210 
mg (83% yield), 91% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 0.7 mL/min); retention times for compound obtained using (S)-L*: 11.1 
min (minor), 13.0 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.41 (d, J = 8.1 Hz, 1H), 8.27 (d, J = 2.1 Hz, 1H), 8.14 
– 8.08 (m, 1H), 7.65 – 7.56 (m, 2H), 7.43 – 7.36 (m, 3H), 7.36 – 7.20 (m, 5H), 7.17 – 
6.98 (m, 3H), 3.76 (ddd, J = 10.8, 9.2, 4.1 Hz, 1H), 3.27 (dq, J = 14.2, 7.1 Hz, 1H), 3.15 
(dt, J = 10.7, 9.2 Hz, 1H), 2.93 (dq, J = 14.5, 7.3 Hz, 1H), 2.73 (dt, J = 15.4, 9.2 Hz, 1H), 
2.64 (ddd, J = 15.5, 9.3, 4.1 Hz, 1H), 0.72 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.2, 143.7, 141.5, 139.8, 137.4, 131.7, 128.7, 128.6, 
128.1, 128.0, 127.4, 126.3, 126.1, 124.7, 124.4, 123.1, 122.7, 120.3, 120.2, 120.0, 119.9, 
118.9, 112.9, 74.2, 49.2, 32.2, 29.3, 10.3; 
FT-IR (ATR) 2935, 1648, 1597, 1476, 1441, 1262, 1213, 1030, 868, 722, 700 cm
-1
; 
HRMS (ESI) m/z (M)
+
 calcd for C30H25
81
BrN2O: 510.1130, found: 510.1136; 





(S)-2-(3,6-Diphenyl-carbazol-9-yl)-1-(indolin-1-yl)-2-phenylbutan-1-one (Fig. 2C, 
Entry 4).  The title compound was synthesized according to General Procedure A from 
3,6-diphenyl-carbazole (159.7 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-
phenylbutan-1-one (179.9 mg, 0.60 mmol).  The product was purified by flash 
chromatography (0%  10% Et2O/hexanes).  Colorless solid.  First run: 286 mg (98% 




The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 10.5 
min (major), 11.7 min (minor). 
1
H NMR (500 MHz, CDCl3) δ 8.52 – 8.45 (m, 3H), 7.82 – 7.75 (m, 4H), 7.73 – 7.68 
(m, 2H), 7.59 – 7.49 (m, 6H), 7.49 – 7.38 (m, 5H), 7.38 – 7.19 (m, 3H), 7.19 – 7.09 (m, 
2H), 3.91 (ddd, J = 10.8, 9.3, 4.0 Hz, 1H), 3.35 (dq, J = 14.2, 7.1 Hz, 1H), 3.26 (dt, J = 
10.7, 9.2 Hz, 1H), 3.04 (dq, J = 14.4, 7.2 Hz, 1H), 2.84 – 2.73 (m, 1H), 2.68 (ddd, J = 
15.5, 9.3, 4.0 Hz, 1H), 0.83 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.4, 143.9, 141.3, 141.1, 137.7, 133.3, 131.8, 128.9, 
128.8, 128.04, 127.99, 127.4, 127.2, 126.8, 125.1, 125.0, 124.6, 124.5, 119.0, 118.3, 
113.8, 74.2, 49.3, 32.4, 29.3, 10.5; 




HRMS (ESI) m/z (M+H)
+
 calcd for C42H35N2O: 583.2744, found: 583.2748; 





(S)-1-(indolin-1-yl)-2-(4-methoxy-carbazol-9-yl)-2-phenylbutan-1-one (Fig. 2C, 
Entry 5).  The title compound was synthesized according to General Procedure A from 
4-methoxy-carbazole (98.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-
1-one (179.9 mg, 0.60 mmol).  3.0 mL of the stock solution of the catalyst were used (3.0 
mol% CuCl).  The product was purified by flash chromatography (0%  10% 
Et2O/hexanes).  Colorless solid.  First run: 196 mg (85% yield), 93% ee.  Second run: 206 
mg (89% yield), 92% ee. 
The ee was determined by HPLC on a Daicel CHIRALCEL
®
 OD column (1% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 6.8 
min (major), 9.0 min (minor). 
1
H NMR (500 MHz, d6-DMSO, 100 °C) δ 8.42 – 8.32 (m, 1H), 8.24 (d, J = 8.3 Hz, 
1H), 7.56 (d, J = 7.2 Hz, 2H), 7.39 – 7.30 (m, 3H), 7.23 – 7.14 (m, 5H), 7.11 (d, J = 7.4 
Hz, 1H), 7.02 (t, J = 7.4 Hz, 1H), 6.81 (dd, J = 10.8, 8.2 Hz, 2H), 4.07 (d, J = 1.3 Hz, 
3H), 3.63 (td, J = 10.0, 5.2 Hz, 1H), 3.23 – 3.01 (m, 3H), 2.62 (dtd, J = 25.4, 15.7, 15.3, 
7.1 Hz, 2H), 0.77 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, d6-DMSO, 100 °C) δ 169.2, 156.4, 144.2, 142.6, 140.5, 139.4, 
132.1, 128.8, 128.3, 128.2, 127.3, 126.7, 124.90, 124.88, 124.6, 123.5, 123.3, 120.2, 
118.4, 113.3, 113.0, 106.4, 102.1, 74.3, 56.0, 49.2, 31.9, 29.0, 10.5; 
FT-IR (ATR) 2932, 1648, 1595, 1476, 1434, 1374, 1258, 1113, 1027, 749, 718 cm
-1
; 
HRMS (ESI) m/z (M+H)
+
 calcd for C31H29N2O2: 461.2224, found: 461.2225; 








(S)-1-(Indolin-1-yl)-2-(3-methyl-indol-1-yl)-2-phenylbutan-1-one (Fig. 2C, Entry 
6).  The title compound was synthesized according to General Procedure A from 3-
methyl-indole (65.5 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-one 
(179.9 mg, 0.60 mmol).  5.0 mL of the stock solution of the catalyst were used (5.0 mol% 
CuCl).  The product was purified by flash chromatography (0%  7% Et2O/hexanes).  
Colorless solid.  First run: 155 mg (79% yield), 92% ee.  Second run: 156 mg (79% 
yield), 92% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 AD column (1% i-
PrOH/hexanes, 0.7 mL/min); retention times for compound obtained using (S)-L*: 8.9 
min (minor), 10.0 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.46 (dt, J = 8.3, 0.8 Hz, 1H), 7.61 (ddd, J = 7.7, 1.6, 
0.7 Hz, 1H), 7.57 – 7.52 (m, 2H), 7.48 – 7.37 (m, 3H), 7.35 (dt, J = 7.9, 0.9 Hz, 1H), 7.28 
(tdd, J = 8.2, 1.5, 0.8 Hz, 1H), 7.21 (q, J = 1.1 Hz, 1H), 7.17 – 7.10 (m, 3H), 7.10 – 7.05 
(m, 1H), 3.27 – 3.14 (m, 2H), 2.97 (dq, J = 14.4, 7.2 Hz, 1H), 2.84 – 2.76 (m, 2H), 2.66 
(dq, J = 14.4, 7.2 Hz, 1H), 2.38 (d, J = 1.1 Hz, 3H), 0.77 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 169.0, 143.9, 137.5, 136.2, 131.4, 130.0, 128.6, 128.3, 
128.0, 127.4, 124.7, 124.4, 124.3, 122.0, 119.4, 119.1, 118.4, 112.9, 111.0, 73.1, 48.4, 
33.4, 28.8, 9.9, 9.8; 
FT-IR (ATR) 2933, 1651, 1598, 1477, 1455, 1381, 1262, 1182, 1019, 739, 702 cm
-1
; 
HRMS (ESI) m/z (M+H)
+
 calcd for C27H27N2O: 395.2118, found: 395.2120; 






phenyl-butan-1-one (Fig. 2C, Entry 7).  The title compound was synthesized according 
to General Procedure A from 3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-indole (34) (137.7 
mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-one (179.9 mg, 0.60 
mmol).  5.0 mL of the stock solution of the catalyst were used (5.0 mol% CuCl).  The 
product was purified by flash chromatography (0%  7% Et2O/hexanes).  Colorless 
solid.  First run: 215 mg (80% yield), 92% ee.  Second run: 214 mg (79% yield), 92% ee. 
The ee was determined by HPLC on a Daicel CHIRALPAK
®
 IB column (0.5% i-
PrOH/hexanes, 0.7 mL/min); retention times for compound obtained using (S)-L*: 8.0 
min (minor), 8.5 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.46 (d, J = 8.2 Hz, 1H), 7.65 (dt, J = 7.8, 1.1 Hz, 1H), 









(dd, J = 7.5, 6.1 Hz, 2H), 3.29 – 3.09 (m, 2H), 3.07 – 2.93 (m, 3H), 2.79 (t, J = 8.1 Hz, 
2H), 2.65 (dq, J = 14.3, 7.2 Hz, 1H), 0.93 (d, J = 1.1 Hz, 9H), 0.79 (td, J = 7.2, 1.1 Hz, 
3H), 0.09 (d, J = 1.1 Hz, 6H); 
13
C NMR (126 MHz, CDCl3) δ 169.0, 143.8, 137.4, 136.1, 131.4, 129.5, 128.6, 128.3, 
128.0, 127.4, 125.1, 124.3, 124.3, 122.0, 119.5, 119.2, 118.5, 113.0, 112.7, 73.1, 63.7, 
48.4, 33.4, 28.9, 28.8, 26.0, 18.3, 10.0, –5.2, –5.3; 




HRMS (ESI) m/z (M+H)
+
 calcd for C34H43N2O2Si: 539.3088, found: 539.3091; 






2C, Entry 8).  The title compound was synthesized according to General Procedure A 
from 5-methoxy-3-methyl-indole (35) (74.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-
yl)-2-phenylbutan-1-one (179.9 mg, 0.60 mmol).  5.0 mL of the stock solution of the 
catalyst were used (5.0 mol% CuCl).  The product was purified by flash chromatography 
(0%  11% Et2O/hexanes).  Colorless solid.  First run: 182 mg (86% yield), 88% ee.  
Second run: 184 mg (87% yield), 88% ee. 
The ee was determined by HPLC on a Daicel CHIRALCEL
®
 OD column (2% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 6.8 
min (minor), 7.7 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.44 (dt, J = 8.0, 0.8 Hz, 1H), 7.56 – 7.50 (m, 2H), 
7.46 – 7.35 (m, 3H), 7.28 (dddd, J = 8.2, 6.6, 1.6, 0.8 Hz, 1H), 7.25 – 7.20 (m, 1H), 7.18 
(d, J = 1.3 Hz, 1H), 7.14 (ddt, J = 6.5, 1.6, 0.7 Hz, 1H), 7.07 (td, J = 7.4, 1.1 Hz, 1H), 
7.03 (d, J = 2.4 Hz, 1H), 6.76 (dd, J = 9.0, 2.6 Hz, 1H), 3.89 (s, 3H), 3.23 (q, J = 8.2 Hz, 
2H), 2.91 (dq, J = 14.4, 7.2 Hz, 1H), 2.81 (td, J = 8.0, 3.1 Hz, 2H), 2.65 (dq, J = 14.4, 7.2 
Hz, 1H), 2.34 (d, J = 1.0 Hz, 3H), 0.76 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 169.0, 153.9, 143.9, 137.7, 131.41, 131.38, 130.5, 
128.5, 128.3, 128.0, 127.4, 125.4, 124.4, 124.3, 118.4, 113.7, 111.8, 110.5, 100.8, 73.1, 
55.7, 48.4, 33.5, 28.8, 9.89, 9.87; 




HRMS (ESI) m/z (M+H)
+
 calcd for C28H29N2O2: 425.2222, found: 425.2224; 









2C, Entry 9).  The title compound was synthesized according to General Procedure A 
from 5-fluoro-3-methyl-indole (74.6 mg, 0.50 mmol) and 2-chloro-1-(indolin-1-yl)-2-
phenylbutan-1-one (179.9 mg, 0.60 mmol).  5.0 mL of the stock solution of the catalyst 
were used (5.0 mol% CuCl).  The product was purified by flash chromatography (0%  
7% Et2O/hexanes).  Colorless solid.  First run: 201 mg (98% yield), 94% ee.  Second run: 
201 mg (97% yield), 94% ee. 
X-ray quality crystals were obtained by slow diffusion of pentane into a saturated 
solution in benzene of a sample synthesized with (S)-L*. 
The ee was determined by HPLC on a Daicel CHIRALCEL
®
 OD column (2% i-
PrOH/hexanes, 1.0 mL/min); retention times for compound obtained using (S)-L*: 7.1 
min (minor), 8.6 min (major). 
1
H NMR (500 MHz, CDCl3) δ 8.47 – 8.39 (m, 1H), 7.56 – 7.48 (m, 2H), 7.48 – 7.36 
(m, 3H), 7.29 – 7.21 (m, 4H), 7.15 (ddq, J = 7.4, 1.7, 1.0 Hz, 1H), 7.08 (td, J = 7.4, 1.1 
Hz, 1H), 6.85 (td, J = 9.1, 2.6 Hz, 1H), 3.20 (q, J = 7.7 Hz, 2H), 2.93 (dq, J = 14.4, 7.2 
Hz, 1H), 2.84 – 2.77 (m, 2H), 2.64 (dq, J = 14.4, 7.2 Hz, 1H), 2.34 (d, J = 1.1 Hz, 3H), 
0.77 (t, J = 7.2 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.8, 157.7 (d, J = 235.8 Hz), 143.8, 137.4, 132.7, 
131.3, 130.5 (d, J = 9.3 Hz), 128.5, 128.4, 128.1, 127.4, 126.3, 124.43, 124.41, 118.4, 
113.5 (d, J = 9.2 Hz), 111.0 (d, J = 4.7 Hz), 110.4 (d, J = 25.8 Hz), 104.0 (d, J = 22.9 
Hz), 73.1, 48.4, 33.4, 28.8, 9.9, 9.8; 
FT-IR (ATR) 2935, 1650, 1598, 1454, 1377, 1263, 1190, 917, 849, 754, 699 cm
-1
; 
HRMS (ESI) m/z (M+H)
+
 calcd for C27H26FN2O: 413.2024, found: 413.2023; 
[]25D (94% ee) = –14.3° (c = 0.50, CHCl3, obtained with (S)-L*). 
 
Fig. 3A.  In a nitrogen-filled glovebox, a stock solution of the catalyst was prepared 
by vigorously stirring CuCl (1.0 mg, 0.010 mmol) and (S)-L* (4.3 mg, 0.012 mmol) in 
toluene (2.0 mL) for 30 min, with warming by a heat gun.  Carbazole (8.4 mg, 0.050 
mmol), LiOt-Bu (6.0 mg, 0.075 mmol), a stir bar, and toluene (1.4 mL) were added to a 4 
mL vial.  The resulting mixture was stirred for 5 min, and then the stock solution of the 
catalyst (100 μL) was added, and stirring was continued for 20 min.  Enantiopure 
electrophile ((+)- or (−)-2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-one; >99% ee; 500 μL 
aliquot of a 0.12 M stock solution; 18.0 mg, 0.060 mmol) was added, then the vial was 
sealed with a PTFE-lined septum cap, taken out of the glovebox, placed ~5 cm from two 
32 W blue LED lamps, and irradiated at −40 °C for 16 h under a nitrogen atmosphere.  
Next, the mixture was allowed to warm to r.t., and dibenzyl ether (19 μL; 0.10 mmol) 
was added as an internal standard.  A portion (~1 mL) of the reaction mixture was passed 
through a short plug of silica to remove traces of copper.  The yield of the product was 
determined by 
1
H NMR analysis using dibenzyl ether as an internal standard.  After 




electrophile and the product were determined by HPLC on a Daicel CHIRALPAK
®
 AD 
column (3% i-PrOH/hexanes, 1.0 mL/min). 
Reaction starting with (+)-2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-one: 
Product shown in Fig. 2B, Entry 1 was synthesized in 95% yield and 94% ee.  Unreacted 
electrophile was found to have 98% ee. 
Unreacted electrophile retention times: 6.2 min (minor), 7.9 min (major); 
Product retention times: 6.3 min (minor), 7.8 min (major). 
Reaction starting with (−)-2-chloro-1-(indolin-1-yl)-2-phenylbutan-1-one: 
Product shown in Fig. 2B, Entry 1 was synthesized in 96% yield and 93% ee.  Unreacted 
electrophile was found to have 98% ee. 
Unreacted electrophile retention times: 6.2 min (major), 7.9 min (minor); 





IV.  Additive and Ligand Effects 
 
In a nitrogen-filled glovebox, a stock solution of the catalyst was prepared by 
vigorously stirring CuCl (1.0 mg, 0.010 mmol) and (S)-L* (4.3 mg, 0.012 mmol) in 
toluene (2.0 mL) for 30 min, with warming by a heat gun.  Carbazole (16.7 mg, 0.10 
mmol), LiOt-Bu (12.0 mg, 0.15 mmol), a stir bar, and toluene (2.8 mL) were added to a 4 
mL vial.  The resulting mixture was stirred for 5 min, and then the stock solution of the 
catalyst (200 µL) was added, and stirring was continued for 20 min.  2-Chloro-1-(indolin-
1-yl)-2-phenylbutan-1-one (1.0 mL aliquot of a 0.12 M stock solution; 36.0 mg, 0.12 
mmol) and then the additive (0.10 mmol) were added to the reaction mixture, and then 
the vial was sealed with a PTFE-lined septum cap, taken out of the glovebox, placed ~5 
cm from two 32 W blue LED lamps, and irradiated at −40 °C for 16 h under a nitrogen 
atmosphere.  Next, the mixture was allowed to warm to r.t., and dibenzyl ether (19 µL; 
0.10 mmol) was added as an internal standard.  A portion (~ 1.5 mL) of the reaction 
mixture was passed through a short plug of silica to remove traces of copper.  The 
recovery of the additive was determined by GC analysis, and the yield of the product was 
determined by 
1
H NMR analysis, both using dibenzyl ether as an internal standard.  After 
purification by preparative TLC (17% EtOAc/hexanes), the ee was determined by HPLC 
on a Daicel CHIRALPAK
®
 AD column (5% i-PrOH/hexanes, 1.0 mL/min); retention 
times: 6.2 min (minor), 7.7 min (major). 
 
Table S1–A.  Effect of additives (1.0 equiv) on cross-couplings (average of two 
experiments). 
 
entry additive yield (%) ee (%) 
recovered 
additive (%) 
1 cyclohexyl bromide  95 94 90 
2 2-nonanone  92 94 96 
3 5-nonanol 90 94 99 
4 methyl octanoate 92 94 98 
5 cis-5-decene 96 95 >99 
6 trans-5-decene 98 95 >99 
7 5-decyne 97 94 >99 
8 valeronitrile 94 94 80 
9 3-phenylpropylamine 7 28 87 
10 N-methyl-2-phenylethylamine 12 86 89 








Table S1–L.  Effect of ligands on cross-couplings (average of two experiments). 
 
entry ligand yield (%) 
1 1,10-phenanthroline  6 
2 neocuproine 12 
3 bpy 2 
4 TMEDA 8 
5 L1 20 











Preparation of complex 1.  In a nitrogen-filled glovebox, an oven-dried 4 mL 
amber-glass vial was charged with carbazole (16.7 mg, 0.10 mmol), a stir bar, and a 
solution of mesitylcopper (18.2 mg, 0.10 mmol) in benzene (400 L).  The mixture was 
stirred for 10 min, and then a solution of (R)-L* (70.8 mg, 0.20 mmol) in benzene (600 
L) was added.  The resulting reaction mixture was stirred for 6 h, and then pentane (2.0 
mL) was added dropwise.  This mixture was stirred for 1 h, during which time a white 
precipitate formed.  The white precipitate was filtered, rinsed with pentane (5 mL), and 
dried to give 64 mg (64% yield) of the desired product as a white powder. 
X-ray quality crystals were obtained by slow evaporation of solvent from a saturated 
solution in a mixture of benzene/ether/pentane. 
1
H NMR (400 MHz, C6D6) δ 8.74 – 8.41 (m, 2H), 7.41 (p, J = 6.6 Hz, 4H), 7.11 (t, J 
= 7.5 Hz, 4H), 7.01 – 6.80 (m, 10H), 6.74 (d, J = 7.6 Hz, 2H), 6.65 (t, J = 7.5 Hz, 2H), 
5.65 (d, J = 7.7 Hz, 2H), 3.56 (d, J = 14.3 Hz, 2H), 3.27 (s, 2H), 2.91 – 2.53 (m, 12H), 
2.16 – 1.78 (m, 8H), 1.30 – 1.15 (m, 2H), 0.95 (t, J = 6.9 Hz, 2H); 
13
C NMR (101 MHz, C6D6) δ 151.0, 147.6, 147.0, 143.1, 142.5, 132.3, 129.8, 129.6, 
129.5, 128.8, 128.6, 128.3, 126.2, 125.6, 123.5, 123.2, 123.1, 120.2, 115.0, 114.4, 61.4, 
38.3, 37.6, 30.6, 30.4, 30.1, 25.0; 
31




Use of complex 1 as a catalyst.  In a nitrogen-filled glovebox, a stock solution of 
catalyst was prepared by vigorously stirring complex 1 (1.9 mg, 2.0 mol) in toluene 
(400 µL) for 30 min.  Carbazole (16.7 mg, 0.10 mmol) and LiOt-Bu (12.0 mg, 0.15 
mmol) were added to a 4 mL vial, followed by a stir bar and toluene (2.8 mL).  The 




added, and the resulting mixture was stirred for 20 min.  2-Chloro-1-(indolin-1-yl)-2-
phenylbutan-1-one (1.0 mL aliquot of a 0.12 M solution in toluene; 36.0 mg, 0.12 mmol) 
was added to the reaction mixture, and then the vial was sealed with a PTFE-lined septum 
cap and taken out of the glovebox.  The vial was placed ~5 cm from two 32 W blue LED 
lamps, and the reaction mixture was irradiated at −40 °C for 16 h under a nitrogen 
atmosphere.  Dibenzyl ether (19 µL, 0.10 mmol) was added as an internal standard, and 
the yield was determined through analysis by 
1
H NMR spectroscopy.  (R)-2-(Carbazol-9-
yl)-1-(indolin-1-yl)-2-phenylbutan-1-one was produced in 92% yield and 94% ee. 
After purification by preparative TLC (17% EtOAc/hexanes), the ee was determined 
by HPLC on a Daicel CHIRALPAK
®
 AD column (5% i-PrOH/hexanes, 1.0 mL/min); 




Stoichiometric reaction of complex 1 in the stoichiometric reaction.  In a 
nitrogen-filled glovebox, complex 1 (23.5 mg, 0.025 mmol), a stir bar, and toluene (3.0 
mL) were added in turn to a 4 mL vial.  The mixture was stirred for 5 min, and then 2-
chloro-1-(indolin-1-yl)-2-phenylbutan-1-one (1.0 mL aliquot of a 0.030 M solution in 
toluene; 9.0 mg, 0.030 mmol) was added.  The vial was sealed with a PTFE-lined septum 
cap and then taken out of the glovebox.  The vial was placed ~5 cm from two 32 W blue 
LED lamps, and the reaction mixture was irradiated at −40 °C for 16 h under a nitrogen 
atmosphere.  Dibenzyl ether (19 µL, 0.10 mmol) was added as an internal standard, and 
the yield was determined through analysis by 
1
H NMR spectroscopy.  (R)-2-(Carbazol-9-
yl)-1-(indolin-1-yl)-2-phenylbutan-1-one was produced in 72% yield and 92% ee. 
After purification by preparative TLC (17% EtOAc/hexanes), the ee was determined 
by HPLC on a Daicel CHIRALPAK
®
 AD column (5% i-PrOH/hexanes, 1.0 mL/min); 





VI.  X-Ray Crystallography/Determination of Absolute Stereochemistry 
 
 
Fig. S2.  Complex 1; structure determined by X-ray diffraction.  Ellipsoids are shown 
at 50% probability level, and H atoms have been omitted for clarity. 
 
Complex 1.  X-ray quality crystals were obtained by slow evaporation of solvent 
from a saturated solution of a sample in a mixture of benzene/ether/pentane.  A crystal of 
C62H54CuNP2 was selected and mounted in a nylon loop in immersion oil.  All 
measurements were made on a Bruker Photon CMOS diffractometer with filtered Mo-Kα 
radiation at a temperature of 100 K.  Using Olex2 (36), the structure was solved with the 
ShelXS structure solution program using Direct Methods and refined with the ShelXL 
refinement package (37) using Least Squares minimization.  The absolute 






Table S2.  Crystal data and structure refinement for p15103. 
Identification code  p15103 
Empirical formula  C62H54CuNP2 
Formula weight  938.54 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Hexagonal 
Space group  P64 
Unit cell dimensions a = 16.9595(8) Å α = 90°. 
 b = 16.9595(8) Å β = 90 °. 
 c = 14.4217(7) Å γ = 120 °. 
Volume 3592.3(4) Å3 
Z 3 
Density (calculated) 1.302 Mg/m3 
Absorption coefficient 0.565 mm-1 
F(000) 1476 
Crystal size 0.16 x 0.05 x 0.03 mm3 
Theta range for data collection 2.402 to 37.529°. 
Index ranges -28<=h<=28, -28<=k<=27, -23<=l<=24 
Reflections collected 102576 
Independent reflections 12026 [R(int) = 0.1009] 
Completeness to theta = 25.000° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.9012 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12026 / 1 / 299 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0659, wR2 = 0.1093 
R indices (all data) R1 = 0.1484, wR2 = 0.1283 
Absolute structure parameter 0.022(4) 




Table S3.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for p15103. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________  
Cu(1) 5000 10000 4144(1) 20(1) 
P(1) 3642(1) 8942(1) 3600(1) 19(1) 
N(1) 5000 10000 5522(2) 20(1) 
C(1) 5452(2) 9711(2) 6091(2) 22(1) 
C(2) 6008(2) 9353(2) 5840(3) 29(1) 
C(3) 6399(3) 9103(3) 6537(3) 42(1) 
C(4) 6247(3) 9199(3) 7476(4) 53(1) 
C(5) 5697(3) 9545(3) 7733(3) 44(1) 
C(6) 5295(2) 9812(2) 7047(2) 29(1) 
C(7) 2863(2) 8513(2) 4613(2) 18(1) 
C(8) 1275(2) 8004(2) 4017(2) 23(1) 
C(9) 1922(2) 7794(2) 4356(2) 20(1) 
C(10) 1700(2) 6881(2) 4380(2) 27(1) 
C(11) 859(2) 6189(2) 4064(3) 34(1) 
C(12) 228(2) 6400(2) 3713(2) 34(1) 
C(13) 435(2) 7310(2) 3685(2) 30(1) 
C(14) -132(2) 7691(3) 3328(3) 41(1) 
C(15) 575(2) 8710(3) 3213(3) 37(1) 
C(16) 1292(2) 8911(2) 3978(2) 25(1) 
C(17) 969(2) 9113(3) 4911(3) 35(1) 
C(18) 1268(3) 10128(3) 4870(3) 41(1) 
C(19) 2104(2) 10512(2) 4266(3) 30(1) 
C(20) 2773(3) 11413(3) 4146(3) 36(1) 
C(21) 3513(3) 11611(2) 3583(3) 35(1) 
C(22) 3585(2) 10927(2) 3158(2) 28(1) 
C(23) 2903(2) 10014(2) 3241(2) 23(1) 
C(24) 2155(2) 9816(2) 3802(2) 25(1) 
C(25) 3021(2) 9275(2) 2791(2) 24(1) 
C(26) 3522(2) 7886(2) 3135(2) 26(1) 
C(27) 2845(3) 7339(3) 2493(3) 38(1) 
C(28) 2720(3) 6491(3) 2252(3) 51(1) 
C(29) 3268(3) 6187(3) 2624(3) 50(1) 
C(30) 3951(3) 6727(3) 3241(3) 41(1) 





Table S4.  Bond lengths [Å] and angles [°] for p15103. 
_____________________________________________________  
Cu(1)-P(1)#1  2.2381(8) 
Cu(1)-P(1)  2.2381(8) 
Cu(1)-N(1)  1.988(4) 
P(1)-C(7)  1.856(3) 
P(1)-C(25)  1.840(3) 
P(1)-C(26)  1.826(3) 
N(1)-C(1)  1.369(4) 
N(1)-C(1)#1  1.369(4) 
C(1)-C(2)  1.402(4) 
C(1)-C(6)  1.430(5) 
C(2)-H(2)  0.9500 
C(2)-C(3)  1.382(5) 
C(3)-H(3)  0.9500 
C(3)-C(4)  1.404(7) 
C(4)-H(4)  0.9500 
C(4)-C(5)  1.377(7) 
C(5)-H(5)  0.9500 
C(5)-C(6)  1.401(5) 
C(6)-C(6)#1  1.429(8) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(7)-C(9)  1.493(4) 
C(8)-C(9)  1.399(4) 
C(8)-C(13)  1.403(4) 
C(8)-C(16)  1.526(5) 
C(9)-C(10)  1.399(4) 
C(10)-H(10)  0.9500 
C(10)-C(11)  1.395(5) 
C(11)-H(11)  0.9500 
C(11)-C(12)  1.384(6) 
C(12)-H(12)  0.9500 
C(12)-C(13)  1.401(5) 
C(13)-C(14)  1.492(5) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(14)-C(15)  1.543(5) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(15)-C(16)  1.548(5) 
C(16)-C(17)  1.555(5) 




C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 
C(17)-C(18)  1.533(5) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(18)-C(19)  1.508(5) 
C(19)-C(20)  1.386(5) 
C(19)-C(24)  1.396(5) 
C(20)-H(20)  0.9500 
C(20)-C(21)  1.388(6) 
C(21)-H(21)  0.9500 
C(21)-C(22)  1.369(5) 
C(22)-H(22)  0.9500 
C(22)-C(23)  1.401(4) 
C(23)-C(24)  1.397(5) 
C(23)-C(25)  1.510(5) 
C(25)-H(25A)  0.9900 
C(25)-H(25B)  0.9900 
C(26)-C(27)  1.404(5) 
C(26)-C(31)  1.377(5) 
C(27)-H(27)  0.9500 
C(27)-C(28)  1.389(6) 
C(28)-H(28)  0.9500 
C(28)-C(29)  1.376(7) 
C(29)-H(29)  0.9500 
C(29)-C(30)  1.384(7) 
C(30)-H(30)  0.9500 
C(30)-C(31)  1.403(5) 















































































































































Table S5.  Anisotropic displacement parameters (Å2x 103) for p15103.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Cu(1) 13(1)  22(1) 22(1)  0 0  8(1) 
P(1) 15(1)  22(1) 17(1)  1(1) 1(1)  7(1) 
N(1) 19(2)  21(2) 22(2)  0 0  12(1) 
C(1) 18(1)  17(1) 26(2)  2(1) -2(1)  6(1) 
C(2) 22(1)  22(1) 42(2)  4(1) -1(1)  11(1) 
C(3) 31(2)  32(2) 67(3)  14(2) -6(2)  18(2) 
C(4) 35(2)  45(2) 66(3)  29(2) -14(2)  11(2) 
C(5) 39(2)  48(2) 27(2)  13(2) -5(2)  7(2) 
C(6) 26(2)  27(2) 24(2)  4(1) -2(1)  5(1) 
C(7) 18(1)  20(1) 14(1)  1(1) 1(1)  7(1) 
C(8) 17(1)  26(2) 18(1)  1(1) 5(1)  5(1) 
C(9) 20(1)  22(1) 15(1)  2(1) 4(1)  8(1) 
C(10) 23(2)  23(2) 28(2)  3(1) 6(1)  7(1) 
C(11) 29(2)  22(2) 38(2)  -1(2) 7(2)  4(1) 
C(12) 23(2)  27(2) 32(2)  -4(1) 4(1)  -2(1) 
C(13) 18(1)  33(2) 28(2)  4(1) 1(1)  4(1) 
C(14) 16(2)  42(2) 51(2)  7(2) -4(2)  4(2) 
C(15) 21(2)  40(2) 46(2)  8(2) -5(2)  12(2) 
C(16) 17(1)  27(2) 30(2)  5(1) 1(1)  10(1) 
C(17) 28(2)  35(2) 42(2)  5(2) 10(2)  17(2) 
C(18) 36(2)  40(2) 55(2)  7(2) 12(2)  25(2) 
C(19) 30(2)  33(2) 32(2)  5(1) -2(1)  20(2) 
C(20) 42(2)  29(2) 43(2)  5(2) -4(2)  22(2) 
C(21) 35(2)  25(2) 39(2)  11(2) -6(2)  12(2) 
C(22) 24(2)  28(2) 26(2)  11(1) -2(1)  9(1) 
C(23) 21(1)  27(2) 21(1)  9(1) -3(1)  11(1) 
C(24) 21(1)  27(2) 28(2)  6(1) -2(1)  13(1) 
C(25) 19(1)  30(2) 16(1)  5(1) -1(1)  6(1) 
C(26) 20(1)  26(2) 27(2)  -2(1) 8(1)  8(1) 
C(27) 31(2)  43(2) 37(2)  -17(2) 1(2)  15(2) 
C(28) 44(2)  46(2) 51(3)  -24(2) 2(2)  13(2) 
C(29) 59(3)  31(2) 52(3)  -6(2) 21(2)  18(2) 
C(30) 48(2)  34(2) 45(2)  7(2) 20(2)  24(2) 





Table S6.  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 10 3) 
for p15103. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(2) 6114 9283 5206 35 
H(3) 6779 8861 6376 51 
H(4) 6527 9024 7940 63 
H(5) 5592 9601 8370 53 
H(7A) 3111 8262 5075 22 
H(7B) 2838 9028 4907 22 
H(10) 2131 6730 4616 32 
H(11) 720 5573 4089 41 
H(12) -343 5931 3491 40 
H(14A) -612 7599 3777 49 
H(14B) -418 7411 2728 49 
H(15A) 287 9089 3300 45 
H(15B) 858 8832 2590 45 
H(17A) 299 8738 4973 42 
H(17B) 1258 8985 5442 42 
H(18A) 790 10224 4589 49 
H(18B) 1415 10405 5496 49 
H(20) 2726 11888 4444 43 
H(21) 3975 12226 3491 42 
H(22) 4111 11077 2797 33 
H(25A) 3367 9502 2205 29 
H(25B) 2418 8743 2646 29 
H(27) 2473 7549 2224 46 
H(28) 2252 6117 1828 61 
H(29) 3177 5605 2456 60 
H(30) 4331 6520 3497 49 






Fig. S3.  Fig. 2B, Entry 1; structure determined by X-ray diffraction.  One of two 
molecules in the asymmetric unit is shown.  Ellipsoids are shown at 50% probability 
level, and H atoms have been omitted for clarity. 
 
(S)-2-(Carbazol-9-yl)-1-(indolin-1-yl)-2-phenylbutan-1-one (Fig. 2B, Entry 1; 2).  
X-ray quality crystals were obtained by slow evaporation of solvent from a saturated 
solution in hexanes of a sample synthesized with (S)-L*.  A crystal of C30H26N2O was 
selected and mounted in a nylon loop in immersion oil.  All measurements were made on 
a Bruker Photon diffractometer with filtered Cu-Kα radiation at a temperature of 100 K.  
Using Olex2 (36), the structure was solved with the ShelXS structure solution program 
using Direct Methods and refined with the ShelXL refinement package (37) using Least 
Squares minimization.  The absolute stereochemistry was determined on the basis of the 






Table S7.  Crystal data and structure refinement for crystal_02. 
Identification code  crystal_02 
Empirical formula  C30H26N2O 
Formula weight  430.53 
Temperature  100.15 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.7927(4) Å α = 90°. 
 b = 14.9886(8) Å β = 90 °. 
 c = 19.0603(10) Å γ = 90 °. 
Volume 2226.3(2) Å3 
Z 4 
Density (calculated) 1.284 Mg/m3 
Absorption coefficient 0.604 mm-1 
F(000) 912 
Crystal size 0.23 x 0.22 x 0.19 mm3 
Theta range for data collection 3.752 to 79.126°. 
Index ranges -8<=h<=9, -18<=k<=18, -24<=l<=24 
Reflections collected 64505 
Independent reflections 4772 [R(int) = 0.0521] 
Completeness to theta = 67.679° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7328 and 0.6567 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4772 / 0 / 299 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1 = 0.0424, wR2 = 0.1097 
R indices (all data) R1 = 0.0427, wR2 = 0.1099 
Absolute structure parameter 0.08(9) 




Table S8.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for crystal_02. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________  
O(1) -6215(3) -5806(1) -1910(1) 31(1) 
N(1) -4132(3) -5199(1) -1243(1) 18(1) 
N(2) -6732(3) -3620(1) -1327(1) 17(1) 
C(1) -5521(3) -5141(2) -1677(1) 20(1) 
C(2) -6172(3) -4200(2) -1919(1) 18(1) 
C(3) -3137(3) -4452(2) -929(1) 20(1) 
C(4) -1987(4) -4886(2) -371(1) 26(1) 
C(5) -2123(3) -5867(2) -524(1) 22(1) 
C(6) -1187(4) -6565(2) -244(2) 28(1) 
C(7) -1583(4) -7437(2) -446(2) 30(1) 
C(8) -2903(4) -7589(2) -912(1) 26(1) 
C(9) -3872(3) -6889(2) -1202(1) 20(1) 
C(10) -3430(3) -6028(2) -1009(1) 18(1) 
C(11) -7734(3) -4354(2) -2411(1) 21(1) 
C(12) -9388(3) -4603(2) -2028(1) 24(1) 
C(13) -4663(3) -3792(2) -2334(1) 19(1) 
C(14) -3752(3) -3039(2) -2118(1) 21(1) 
C(15) -2413(4) -2696(2) -2516(1) 25(1) 
C(16) -1963(4) -3097(2) -3144(2) 30(1) 
C(17) -2837(4) -3853(2) -3364(1) 30(1) 
C(18) -4173(4) -4198(2) -2964(1) 25(1) 
C(19) -7337(3) -3891(2) -662(1) 17(1) 
C(20) -7132(3) -4685(2) -280(1) 19(1) 
C(21) -7787(3) -4723(2) 398(1) 23(1) 
C(22) -8680(3) -4011(2) 704(1) 22(1) 
C(23) -8961(3) -3241(2) 321(1) 19(1) 
C(24) -8292(3) -3185(2) -360(1) 16(1) 
C(25) -8389(3) -2488(2) -875(1) 16(1) 
C(26) -9231(3) -1665(2) -880(1) 19(1) 
C(27) -9124(3) -1134(2) -1473(1) 23(1) 
C(28) -8182(3) -1423(2) -2056(1) 23(1) 
C(29) -7357(3) -2238(2) -2065(1) 20(1) 





Table S9.  Bond lengths [Å] and angles [°] for crystal_02. 
_____________________________________________________  
O(1)-C(1)  1.218(3) 
N(1)-C(1)  1.364(3) 
N(1)-C(3)  1.488(3) 
N(1)-C(10)  1.428(3) 
N(2)-C(2)  1.489(3) 
N(2)-C(19)  1.412(3) 
N(2)-C(30)  1.408(3) 
C(1)-C(2)  1.569(3) 
C(2)-C(11)  1.554(3) 
C(2)-C(13)  1.543(3) 
C(3)-C(4)  1.537(3) 
C(4)-C(5)  1.502(4) 
C(5)-C(6)  1.382(4) 
C(5)-C(10)  1.397(3) 
C(6)-C(7)  1.397(4) 
C(7)-C(8)  1.378(4) 
C(8)-C(9)  1.405(4) 
C(9)-C(10)  1.385(3) 
C(11)-C(12)  1.527(4) 
C(13)-C(14)  1.396(4) 
C(13)-C(18)  1.401(3) 
C(14)-C(15)  1.389(4) 
C(15)-C(16)  1.384(4) 
C(16)-C(17)  1.387(4) 
C(17)-C(18)  1.390(4) 
C(19)-C(20)  1.404(3) 
C(19)-C(24)  1.416(3) 
C(20)-C(21)  1.390(4) 
C(21)-C(22)  1.401(4) 
C(22)-C(23)  1.383(3) 
C(23)-C(24)  1.401(3) 
C(24)-C(25)  1.436(3) 
C(25)-C(26)  1.396(3) 
C(25)-C(30)  1.405(3) 
C(26)-C(27)  1.385(3) 
C(27)-C(28)  1.400(3) 
C(28)-C(29)  1.381(3) 




































































Table S10.  Anisotropic displacement parameters (Å2x 103) for crystal_02.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 35(1)  17(1) 42(1)  -7(1) -19(1)  2(1) 
N(1) 19(1)  14(1) 21(1)  -2(1) -3(1)  2(1) 
N(2) 17(1)  16(1) 17(1)  -2(1) -1(1)  1(1) 
C(1) 19(1)  17(1) 24(1)  -4(1) -3(1)  3(1) 
C(2) 17(1)  16(1) 19(1)  -3(1) -3(1)  2(1) 
C(3) 16(1)  19(1) 26(1)  -1(1) -5(1)  -2(1) 
C(4) 26(1)  24(1) 29(1)  0(1) -10(1)  1(1) 
C(5) 21(1)  25(1) 21(1)  2(1) -2(1)  2(1) 
C(6) 29(1)  28(1) 29(1)  2(1) -7(1)  6(1) 
C(7) 35(2)  25(1) 29(1)  5(1) -1(1)  10(1) 
C(8) 34(2)  19(1) 25(1)  1(1) 5(1)  4(1) 
C(9) 22(1)  19(1) 20(1)  1(1) 5(1)  1(1) 
C(10) 17(1)  20(1) 17(1)  2(1) 3(1)  5(1) 
C(11) 20(1)  22(1) 20(1)  -2(1) -5(1)  4(1) 
C(12) 18(1)  26(1) 28(1)  -3(1) -9(1)  -1(1) 
C(13) 21(1)  19(1) 16(1)  -1(1) 1(1)  6(1) 
C(14) 19(1)  22(1) 22(1)  0(1) 3(1)  4(1) 
C(15) 20(1)  23(1) 32(1)  7(1) 1(1)  3(1) 
C(16) 24(1)  37(2) 29(1)  10(1) 7(1)  10(1) 
C(17) 28(1)  42(2) 19(1)  1(1) 7(1)  14(1) 
C(18) 24(1)  29(1) 21(1)  -4(1) -1(1)  8(1) 
C(19) 13(1)  17(1) 20(1)  -2(1) -3(1)  -2(1) 
C(20) 17(1)  16(1) 26(1)  1(1) -4(1)  -2(1) 
C(21) 20(1)  20(1) 29(1)  8(1) -6(1)  -6(1) 
C(22) 23(1)  25(1) 20(1)  4(1) -1(1)  -6(1) 
C(23) 16(1)  20(1) 20(1)  -1(1) 0(1)  -3(1) 
C(24) 13(1)  16(1) 19(1)  -2(1) -2(1)  -2(1) 
C(25) 13(1)  19(1) 16(1)  -1(1) 0(1)  -2(1) 
C(26) 18(1)  20(1) 20(1)  -4(1) 2(1)  2(1) 
C(27) 23(1)  20(1) 25(1)  1(1) 2(1)  4(1) 
C(28) 23(1)  23(1) 22(1)  5(1) 3(1)  4(1) 
C(29) 19(1)  26(1) 15(1)  1(1) 1(1)  3(1) 





Table S11.  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 10 3) 
for crystal_02. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(3A) -3916 -4008 -713 24 
H(3B) -2434 -4149 -1291 24 
H(4A) -787 -4678 -415 31 
H(4B) -2406 -4750 108 31 
H(6) -287 -6453 80 34 
H(7) -944 -7924 -263 36 
H(8) -3166 -8185 -1042 31 
H(9) -4793 -7002 -1516 24 
H(11A) -7938 -3804 -2686 25 
H(11B) -7447 -4836 -2746 25 
H(12A) -10300 -4711 -2371 36 
H(12B) -9726 -4112 -1717 36 
H(12C) -9198 -5143 -1750 36 
H(14) -4053 -2754 -1690 25 
H(15) -1804 -2186 -2358 30 
H(16) -1063 -2856 -3422 36 
H(17) -2521 -4136 -3791 36 
H(18) -4760 -4717 -3120 30 
H(20) -6559 -5183 -479 23 
H(21) -7622 -5252 664 27 
H(22) -9091 -4057 1172 27 
H(23) -9594 -2759 516 23 
H(26) -9867 -1473 -483 23 
H(27) -9691 -573 -1485 27 
H(28) -8109 -1048 -2456 28 






Fig. S4.  Fig. 2B, Entry 5; structure determined by X-ray diffraction.  One of two 
molecules in the asymmetric unit is shown.  Ellipsoids are shown at 50% probability 
level, and H atoms have been omitted for clarity. 
 
 (R)-2-(Carbazol-9-yl)-2-cyclopentyl-1-(indolin-1-yl)propan-1-one (Fig. 2B, Entry 
5; 3).  X-ray quality crystals were obtained by slow diffusion of pentane into a saturated 
solution in benzene of a sample synthesized with (S)-L*.  A crystal of C28H28N2O was 
selected and mounted in a nylon loop in immersion oil.  All measurements were made on 
a Bruker Photon CMOS diffractometer with filtered Cu-Kα radiation at a temperature of 
100 K.  Using Olex2 (36), the structure was solved with the ShelXS structure solution 
program using Direct Methods and refined with the ShelXL refinement package (37) 
using Least Squares minimization.  The absolute stereochemistry was determined on the 






Table S12.  Crystal data and structure refinement for P15318. 
Identification code  P15318 
Empirical formula  C28H28N2O 
Formula weight  408.52 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 11.6751(3) Å α = 90°. 
 b = 18.0248(5) Å β = 90 °. 
 c = 20.3121(5) Å γ = 90 °. 
Volume 4274.51(19) Å3 
Z 8 
Density (calculated) 1.270 Mg/m3 
Absorption coefficient 0.596 mm-1 
F(000) 1744 
Crystal size 0.2 x 0.15 x 0.1 mm3 
Theta range for data collection 3.278 to 70.105°. 
Index ranges -14<=h<=8, -21<=k<=21, -24<=l<=24 
Reflections collected 38560 
Independent reflections 8073 [R(int) = 0.0452] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7533 and 0.6918 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8073 / 0 / 561 
Goodness-of-fit on F2 1.076 
Final R indices [I>2sigma(I)] R1 = 0.0313, wR2 = 0.0700 
R indices (all data) R1 = 0.0352, wR2 = 0.0719 
Absolute structure parameter 0.10(9) 




Table S13.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for P15318. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________  
O(1) 6831(1) 11992(1) 2174(1) 19(1) 
N(1) 7856(1) 11515(1) 1331(1) 15(1) 
N(2) 6981(1) 12821(1) 621(1) 14(1) 
C(1) 7022(2) 11963(1) 1580(1) 14(1) 
C(2) 6254(2) 12418(1) 1102(1) 14(1) 
C(3) 5448(2) 11854(1) 781(1) 17(1) 
C(4) 5553(2) 13003(1) 1498(1) 17(1) 
C(5) 4881(2) 13534(1) 1033(1) 21(1) 
C(6) 3628(2) 13494(1) 1253(1) 23(1) 
C(7) 3707(2) 13302(1) 1982(1) 24(1) 
C(8) 4646(2) 12710(1) 1988(1) 20(1) 
C(9) 8245(2) 11444(1) 633(1) 18(1) 
C(10) 9045(2) 10771(1) 632(1) 19(1) 
C(11) 9343(2) 10669(1) 1346(1) 16(1) 
C(12) 8609(2) 11090(1) 1740(1) 15(1) 
C(13) 8697(2) 11072(1) 2422(1) 20(1) 
C(14) 9560(2) 10639(1) 2696(1) 21(1) 
C(15) 10315(2) 10238(1) 2308(1) 20(1) 
C(16) 10200(2) 10250(1) 1626(1) 19(1) 
C(17) 7861(2) 13293(1) 826(1) 15(1) 
C(18) 8391(2) 13349(1) 1442(1) 18(1) 
C(19) 9320(2) 13827(1) 1498(1) 22(1) 
C(20) 9704(2) 14254(1) 966(1) 24(1) 
C(21) 9167(2) 14207(1) 362(1) 22(1) 
C(22) 8244(2) 13719(1) 290(1) 16(1) 
C(23) 7577(2) 13497(1) -273(1) 16(1) 
C(24) 7629(2) 13709(1) -935(1) 20(1) 
C(25) 6928(2) 13359(1) -1385(1) 22(1) 
C(26) 6174(2) 12808(1) -1174(1) 21(1) 
C(27) 6096(2) 12591(1) -520(1) 17(1) 
C(28) 6811(2) 12938(1) -60(1) 14(1) 
O(2) 6429(1) 9881(1) 551(1) 18(1) 
N(3) 5317(1) 9042(1) 1076(1) 15(1) 
N(4) 6720(1) 7947(1) 433(1) 15(1) 
C(29) 6080(2) 9242(1) 602(1) 15(1) 
C(30) 6456(2) 8652(1) 88(1) 15(1) 
C(31) 5455(2) 8600(1) -402(1) 17(1) 




C(33) 7493(2) 9526(1) -780(1) 18(1) 
C(34) 8661(2) 9480(1) -1121(1) 21(1) 
C(35) 8920(2) 8642(1) -1170(1) 20(1) 
C(36) 8128(2) 8262(1) -662(1) 18(1) 
C(37) 4753(2) 8311(1) 1183(1) 19(1) 
C(38) 3647(2) 8507(1) 1554(1) 22(1) 
C(39) 3953(2) 9229(1) 1881(1) 18(1) 
C(40) 4916(2) 9534(1) 1578(1) 15(1) 
C(41) 5388(2) 10201(1) 1791(1) 17(1) 
C(42) 4848(2) 10565(1) 2311(1) 21(1) 
C(43) 3880(2) 10270(1) 2610(1) 23(1) 
C(44) 3434(2) 9596(1) 2399(1) 22(1) 
C(45) 6518(2) 7213(1) 236(1) 15(1) 
C(46) 5802(2) 6914(1) -251(1) 19(1) 
C(47) 5775(2) 6151(1) -327(1) 24(1) 
C(48) 6437(2) 5676(1) 63(1) 26(1) 
C(49) 7132(2) 5962(1) 546(1) 22(1) 
C(50) 7165(2) 6731(1) 641(1) 17(1) 
C(51) 7797(2) 7188(1) 1094(1) 17(1) 
C(52) 8569(2) 7022(1) 1601(1) 22(1) 
C(53) 9074(2) 7600(1) 1942(1) 24(1) 
C(54) 8804(2) 8334(1) 1790(1) 22(1) 
C(55) 8025(2) 8514(1) 1301(1) 18(1) 





Table S14.  Bond lengths [Å] and angles [°] for P15318. 
_____________________________________________________  
O(1)-C(1)  1.228(2) 
N(1)-C(1)  1.364(3) 
N(1)-C(9)  1.494(2) 
N(1)-C(12)  1.431(2) 
N(2)-C(2)  1.486(2) 
N(2)-C(17)  1.398(3) 
N(2)-C(28)  1.412(2) 
C(1)-C(2)  1.554(3) 
C(2)-C(3)  1.531(3) 
C(2)-C(4)  1.558(3) 
C(4)-C(5)  1.557(3) 
C(4)-C(8)  1.546(3) 
C(5)-C(6)  1.532(3) 
C(6)-C(7)  1.524(3) 
C(7)-C(8)  1.531(3) 
C(9)-C(10)  1.532(3) 
C(10)-C(11)  1.502(3) 
C(11)-C(12)  1.396(3) 
C(11)-C(16)  1.377(3) 
C(12)-C(13)  1.390(3) 
C(13)-C(14)  1.391(3) 
C(14)-C(15)  1.385(3) 
C(15)-C(16)  1.391(3) 
C(17)-C(18)  1.400(3) 
C(17)-C(22)  1.406(3) 
C(18)-C(19)  1.390(3) 
C(19)-C(20)  1.400(3) 
C(20)-C(21)  1.379(3) 
C(21)-C(22)  1.399(3) 
C(22)-C(23)  1.440(3) 
C(23)-C(24)  1.399(3) 
C(23)-C(28)  1.417(3) 
C(24)-C(25)  1.379(3) 
C(25)-C(26)  1.394(3) 
C(26)-C(27)  1.389(3) 
C(27)-C(28)  1.401(3) 
O(2)-C(29)  1.225(2) 
N(3)-C(29)  1.361(3) 
N(3)-C(37)  1.489(2) 
N(3)-C(40)  1.429(2) 




N(4)-C(45)  1.402(3) 
N(4)-C(56)  1.402(3) 
C(29)-C(30)  1.554(3) 
C(30)-C(31)  1.538(3) 
C(30)-C(32)  1.554(3) 
C(32)-C(33)  1.532(3) 
C(32)-C(36)  1.545(3) 
C(33)-C(34)  1.531(3) 
C(34)-C(35)  1.543(3) 
C(35)-C(36)  1.546(3) 
C(37)-C(38)  1.537(3) 
C(38)-C(39)  1.504(3) 
C(39)-C(40)  1.395(3) 
C(39)-C(44)  1.381(3) 
C(40)-C(41)  1.392(3) 
C(41)-C(42)  1.394(3) 
C(42)-C(43)  1.389(3) 
C(43)-C(44)  1.390(3) 
C(45)-C(46)  1.404(3) 
C(45)-C(50)  1.414(3) 
C(46)-C(47)  1.384(3) 
C(47)-C(48)  1.399(3) 
C(48)-C(49)  1.375(3) 
C(49)-C(50)  1.401(3) 
C(50)-C(51)  1.438(3) 
C(51)-C(52)  1.401(3) 
C(51)-C(56)  1.410(3) 
C(52)-C(53)  1.382(3) 
C(53)-C(54)  1.394(3) 
C(54)-C(55)  1.386(3) 





























































































































Table S15.  Anisotropic displacement parameters (Å2x 103) for P15318.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2 a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 21(1)  24(1) 13(1)  1(1) 1(1)  4(1) 
N(1) 16(1)  17(1) 12(1)  0(1) -1(1)  1(1) 
N(2) 13(1)  14(1) 14(1)  0(1) -1(1)  -1(1) 
C(1) 14(1)  15(1) 14(1)  0(1) -1(1)  -3(1) 
C(2) 14(1)  16(1) 12(1)  1(1) 2(1)  -1(1) 
C(3) 16(1)  19(1) 15(1)  1(1) -1(1)  -2(1) 
C(4) 16(1)  18(1) 17(1)  1(1) 0(1)  2(1) 
C(5) 20(1)  20(1) 22(1)  2(1) 0(1)  5(1) 
C(6) 18(1)  20(1) 30(1)  2(1) -3(1)  4(1) 
C(7) 19(1)  27(1) 27(1)  -5(1) 4(1)  2(1) 
C(8) 18(1)  26(1) 17(1)  1(1) 3(1)  3(1) 
C(9) 19(1)  20(1) 13(1)  1(1) 1(1)  3(1) 
C(10) 23(1)  18(1) 16(1)  -1(1) 1(1)  4(1) 
C(11) 16(1)  14(1) 18(1)  1(1) 2(1)  -3(1) 
C(12) 14(1)  14(1) 18(1)  2(1) -2(1)  -3(1) 
C(13) 18(1)  22(1) 18(1)  1(1) 0(1)  2(1) 
C(14) 20(1)  24(1) 18(1)  5(1) -2(1)  -2(1) 
C(15) 17(1)  17(1) 25(1)  5(1) -2(1)  0(1) 
C(16) 17(1)  16(1) 24(1)  0(1) 2(1)  1(1) 
C(17) 12(1)  13(1) 19(1)  -2(1) 2(1)  1(1) 
C(18) 18(1)  17(1) 18(1)  -4(1) -1(1)  1(1) 
C(19) 20(1)  21(1) 25(1)  -10(1) -3(1)  1(1) 
C(20) 19(1)  17(1) 36(1)  -9(1) 2(1)  -4(1) 
C(21) 20(1)  16(1) 29(1)  -4(1) 8(1)  -1(1) 
C(22) 17(1)  11(1) 22(1)  -2(1) 4(1)  3(1) 
C(23) 15(1)  15(1) 20(1)  1(1) 3(1)  4(1) 
C(24) 18(1)  18(1) 22(1)  6(1) 5(1)  5(1) 
C(25) 22(1)  28(1) 16(1)  5(1) 2(1)  7(1) 
C(26) 20(1)  26(1) 17(1)  -1(1) -3(1)  6(1) 
C(27) 16(1)  19(1) 17(1)  1(1) -1(1)  1(1) 
C(28) 14(1)  15(1) 15(1)  1(1) 1(1)  5(1) 
O(2) 22(1)  14(1) 19(1)  0(1) 4(1)  -2(1) 
N(3) 17(1)  13(1) 16(1)  -2(1) 2(1)  -2(1) 
N(4) 16(1)  14(1) 15(1)  0(1) -2(1)  0(1) 
C(29) 14(1)  16(1) 16(1)  1(1) -2(1)  1(1) 
C(30) 16(1)  13(1) 14(1)  0(1) -1(1)  0(1) 
C(31) 17(1)  16(1) 17(1)  1(1) -2(1)  0(1) 




C(33) 20(1)  17(1) 17(1)  2(1) 1(1)  4(1) 
C(34) 24(1)  19(1) 20(1)  4(1) 6(1)  0(1) 
C(35) 20(1)  21(1) 18(1)  -1(1) 4(1)  2(1) 
C(36) 19(1)  16(1) 19(1)  1(1) 2(1)  2(1) 
C(37) 20(1)  14(1) 23(1)  0(1) 5(1)  -4(1) 
C(38) 16(1)  22(1) 28(1)  -1(1) 3(1)  -3(1) 
C(39) 15(1)  18(1) 21(1)  2(1) 0(1)  2(1) 
C(40) 17(1)  15(1) 14(1)  1(1) 0(1)  3(1) 
C(41) 19(1)  18(1) 15(1)  2(1) -1(1)  1(1) 
C(42) 29(1)  18(1) 16(1)  -1(1) -2(1)  2(1) 
C(43) 28(1)  24(1) 18(1)  -1(1) 5(1)  8(1) 
C(44) 19(1)  24(1) 22(1)  5(1) 6(1)  5(1) 
C(45) 15(1)  14(1) 17(1)  0(1) 5(1)  1(1) 
C(46) 18(1)  18(1) 20(1)  -3(1) 1(1)  -1(1) 
C(47) 23(1)  20(1) 28(1)  -9(1) 2(1)  -2(1) 
C(48) 30(1)  14(1) 34(1)  -3(1) 6(1)  0(1) 
C(49) 23(1)  16(1) 28(1)  3(1) 6(1)  4(1) 
C(50) 17(1)  17(1) 18(1)  2(1) 4(1)  2(1) 
C(51) 16(1)  20(1) 15(1)  3(1) 5(1)  1(1) 
C(52) 22(1)  25(1) 18(1)  7(1) 3(1)  6(1) 
C(53) 19(1)  38(1) 15(1)  6(1) -1(1)  4(1) 
C(54) 20(1)  31(1) 15(1)  0(1) 0(1)  -3(1) 
C(55) 19(1)  19(1) 15(1)  1(1) 1(1)  0(1) 





Table S16.  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 10 3) 
for P15318. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(3A) 4838 12118 545 25 
H(3B) 5109 11538 1122 25 
H(3C) 5880 11547 470 25 
H(4) 6110 13311 1753 20 
H(5A) 5175 14048 1072 25 
H(5B) 4958 13373 569 25 
H(6A) 3237 13976 1187 27 
H(6B) 3208 13105 1008 27 
H(7A) 2973 13102 2150 29 
H(7B) 3929 13739 2248 29 
H(8A) 4341 12224 1842 25 
H(8B) 4978 12654 2434 25 
H(9A) 8658 11897 490 21 
H(9B) 7586 11363 335 21 
H(10A) 8651 10327 456 23 
H(10B) 9739 10868 366 23 
H(13) 8185 11347 2692 23 
H(14) 9635 10618 3161 25 
H(15) 10909 9956 2507 24 
H(16) 10708 9972 1357 22 
H(18) 8126 13070 1809 21 
H(19) 9707 13865 1908 27 
H(20) 10337 14579 1021 29 
H(21) 9420 14501 2 26 
H(24) 8139 14089 -1073 24 
H(25) 6959 13493 -1837 26 
H(26) 5697 12573 -1490 25 
H(27) 5572 12216 -389 21 
H(31A) 5704 8330 -796 25 
H(31B) 5209 9100 -527 25 
H(31C) 4815 8335 -197 25 
H(32) 8125 9061 74 18 
H(33A) 6861 9440 -1096 22 
H(33B) 7384 10014 -566 22 
H(34A) 9255 9736 -858 25 
H(34B) 8629 9708 -1564 25 




H(35B) 8757 8457 -1619 23 
H(36A) 7538 7959 -886 21 
H(36B) 8576 7937 -365 21 
H(37A) 5245 7978 1448 23 
H(37B) 4579 8066 758 23 
H(38A) 2995 8569 1248 26 
H(38B) 3454 8122 1884 26 
H(41) 6054 10401 1590 21 
H(42) 5147 11024 2464 25 
H(43) 3520 10531 2961 28 
H(44) 2780 9389 2608 26 
H(46) 5348 7227 -522 23 
H(47) 5290 5943 -654 28 
H(48) 6406 5155 -7 31 
H(49) 7584 5642 813 27 
H(52) 8743 6522 1709 26 
H(53) 9609 7496 2282 29 
H(54) 9165 8722 2029 26 







Fig. S5.  Fig. 2C, Entry 9; structure determined by X-ray diffraction.  One of two 
molecules in the asymmetric unit is shown.  Ellipsoids are shown at 50% probability 
level, and H atoms have been omitted for clarity. 
 
(S)-2-(5-Fluoro-3-methyl-indol-1-yl)-1-(indolin-1-yl)-2-phenylbutan-1-one (Fig. 
2C, Entry 9; 4).  X-ray quality crystals were obtained by slow diffusion of pentane into a 
saturated solution in benzene of a sample synthesized with (S)-L*.  A crystal of 
C27H25FN2O was selected and mounted in a nylon loop in immersion oil.  All 
measurements were made on a Bruker Photon diffractometer with filtered Cu-Kα 
radiation at a temperature of 100 K.  Using Olex2 (36), the structure was solved with the 
ShelXS structure solution program using Direct Methods and refined with the ShelXL 
refinement package (37) using Least Squares minimization.  The absolute 






Table S17.  Crystal data and structure refinement for P15247. 
Identification code  P15247 
Empirical formula  C27 H25 F N2 O 
Formula weight  412.49 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  C2 
Unit cell dimensions a = 35.820(2) Å a= 90°. 
 b = 6.2695(4) Å b= 105.840(3)°. 
 c = 19.1086(12) Å g = 90°. 
Volume 4128.4(4) Å3 
Z 8 
Density (calculated) 1.327 Mg/m3 
Absorption coefficient 0.696 mm-1 
F(000) 1744 
Crystal size 0.300 x 0.050 x 0.050 mm3 
Theta range for data collection 2.403 to 79.586°. 
Index ranges -45<=h<=44, -7<=k<=7, -24<=l<=24 
Reflections collected 38825 
Independent reflections 8771 [R(int) = 0.0580] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9891 and 0.9186 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8771 / 1 / 563 
Goodness-of-fit on F2 1.037 
Final R indices [I>2sigma(I)] R1 = 0.0351, wR2 = 0.0745 
R indices (all data) R1 = 0.0425, wR2 = 0.0777 
Absolute structure parameter 0.05(7) 
Extinction coefficient n/a 




Table S18.  Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for P15247.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) 3754(1) 3436(3) 2418(1) 19(1) 
C(1) 3735(1) 1785(4) 2067(1) 14(1) 
N(1) 4036(1) 369(3) 2201(1) 14(1) 
C(2) 4366(1) 512(4) 2821(1) 14(1) 
C(3) 4467(1) 2102(4) 3343(1) 17(1) 
C(4) 4802(1) 1809(4) 3915(1) 21(1) 
C(5) 5029(1) -9(4) 3961(1) 24(1) 
C(6) 4923(1) -1580(4) 3428(1) 23(1) 
C(7) 4591(1) -1324(4) 2860(1) 17(1) 
C(8) 4421(1) -2806(4) 2240(1) 20(1) 
C(9) 4043(1) -1707(4) 1822(1) 17(1) 
C(10) 3348(1) 1265(3) 1481(1) 13(1) 
N(2) 3429(1) 494(3) 806(1) 14(1) 
C(11) 3667(1) 1556(4) 453(1) 14(1) 
C(12) 3889(1) 3410(4) 642(1) 17(1) 
C(13) 4111(1) 4058(4) 190(1) 21(1) 
C(14) 4110(1) 2854(4) -424(1) 22(1) 
F(1) 4336(1) 3559(3) -848(1) 34(1) 
C(15) 3900(1) 1032(4) -621(1) 20(1) 
C(16) 3668(1) 362(4) -174(1) 16(1) 
C(17) 3420(1) -1436(4) -205(1) 17(1) 
C(19) 3320(1) -3092(4) -793(1) 23(1) 
C(18) 3288(1) -1305(4) 401(1) 15(1) 
C(20) 3121(1) -354(3) 1808(1) 15(1) 
C(21) 2750(1) -1059(4) 1421(1) 17(1) 
C(22) 2533(1) -2395(4) 1743(1) 22(1) 
C(23) 2682(1) -3068(4) 2458(2) 25(1) 
C(24) 3046(1) -2380(4) 2846(1) 24(1) 
C(25) 3262(1) -1035(4) 2528(1) 19(1) 
C(26) 3119(1) 3401(4) 1317(1) 16(1) 
C(27) 2775(1) 3412(4) 638(1) 21(1) 
O(101) 3773(1) 7642(3) 7525(1) 21(1) 
C(101) 3818(1) 9287(4) 7212(1) 14(1) 
N(101) 4160(1) 10366(3) 7399(1) 15(1) 
C(102) 4484(1) 9768(4) 7989(1) 16(1) 
C(103) 4525(1) 8018(4) 8452(1) 20(1) 
C(104) 4869(1) 7859(5) 9013(1) 25(1) 




C(106) 5115(1) 11086(5) 8632(1) 26(1) 
C(107) 4778(1) 11279(4) 8068(1) 19(1) 
C(108) 4667(1) 12950(4) 7491(1) 22(1) 
C(109) 4246(1) 12457(5) 7106(2) 34(1) 
C(110) 3477(1) 10174(3) 6588(1) 14(1) 
N(102) 3610(1) 10532(3) 5932(1) 14(1) 
C(111) 3822(1) 9098(3) 5639(1) 14(1) 
C(112) 4008(1) 7195(4) 5916(1) 16(1) 
C(113) 4204(1) 6104(4) 5496(1) 20(1) 
C(114) 4214(1) 6923(4) 4825(1) 21(1) 
F(101) 4418(1) 5798(3) 4441(1) 30(1) 
C(115) 4029(1) 8750(4) 4528(1) 20(1) 
C(116) 3823(1) 9862(4) 4939(1) 16(1) 
C(117) 3591(1) 11757(4) 4806(1) 17(1) 
C(118) 3464(1) 12086(4) 5408(1) 16(1) 
C(119) 3502(1) 13114(4) 4135(1) 24(1) 
C(120) 3137(1) 8581(4) 6411(1) 15(1) 
C(121) 2980(1) 7863(4) 5704(1) 18(1) 
C(122) 2651(1) 6559(4) 5527(1) 22(1) 
C(123) 2475(1) 5966(4) 6054(1) 22(1) 
C(124) 2630(1) 6650(4) 6765(1) 20(1) 
C(125) 2959(1) 7928(4) 6945(1) 17(1) 
C(126) 3331(1) 12350(4) 6826(1) 16(1) 





Table S19.  Bond lengths [Å] and angles [°] for  P15247. 
_____________________________________________________  
O(1)-C(1)  1.225(3) 
C(1)-N(1)  1.364(3) 
C(1)-C(10)  1.560(3) 
N(1)-C(2)  1.431(3) 
N(1)-C(9)  1.493(3) 
C(2)-C(3)  1.387(3) 
C(2)-C(7)  1.394(3) 
C(3)-C(4)  1.397(3) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.389(4) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.392(4) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.384(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.498(3) 
C(8)-C(9)  1.536(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-N(2)  1.478(3) 
C(10)-C(20)  1.538(3) 
C(10)-C(26)  1.557(3) 
N(2)-C(18)  1.384(3) 
N(2)-C(11)  1.392(3) 
C(11)-C(12)  1.398(3) 
C(11)-C(16)  1.415(3) 
C(12)-C(13)  1.385(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.395(4) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.364(4) 
C(14)-F(1)  1.366(3) 
C(15)-C(16)  1.407(3) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.426(3) 
C(17)-C(18)  1.369(3) 
C(17)-C(19)  1.499(3) 
C(19)-H(19A)  0.9800 




C(19)-H(19C)  0.9800 
C(18)-H(18)  0.9500 
C(20)-C(25)  1.396(3) 
C(20)-C(21)  1.404(3) 
C(21)-C(22)  1.394(3) 
C(21)-H(21)  0.9500 
C(22)-C(23)  1.390(4) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.382(4) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.392(3) 
C(24)-H(24)  0.9500 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.528(3) 
C(26)-H(26A)  0.9900 
C(26)-H(26B)  0.9900 
C(27)-H(27A)  0.9800 
C(27)-H(27B)  0.9800 
C(27)-H(27C)  0.9800 
O(101)-C(101)  1.225(3) 
C(101)-N(101)  1.357(3) 
C(101)-C(110)  1.559(3) 
N(101)-C(102)  1.430(3) 
N(101)-C(109)  1.490(3) 
C(102)-C(103)  1.392(3) 
C(102)-C(107)  1.394(3) 
C(103)-C(104)  1.400(3) 
C(103)-H(103)  0.9500 
C(104)-C(105)  1.382(4) 
C(104)-H(104)  0.9500 
C(105)-C(106)  1.387(4) 
C(105)-H(105)  0.9500 
C(106)-C(107)  1.386(3) 
C(106)-H(106)  0.9500 
C(107)-C(108)  1.495(4) 
C(108)-C(109)  1.516(3) 
C(108)-H(10A)  0.9900 
C(108)-H(10B)  0.9900 
C(109)-H(10C)  0.9900 
C(109)-H(10D)  0.9900 
C(110)-N(102)  1.475(3) 
C(110)-C(120)  1.539(3) 




N(102)-C(111)  1.391(3) 
N(102)-C(118)  1.393(3) 
C(111)-C(112)  1.398(3) 
C(111)-C(116)  1.422(3) 
C(112)-C(113)  1.384(3) 
C(112)-H(112)  0.9500 
C(113)-C(114)  1.391(3) 
C(113)-H(113)  0.9500 
C(114)-F(101)  1.365(3) 
C(114)-C(115)  1.366(4) 
C(115)-C(116)  1.402(3) 
C(115)-H(115)  0.9500 
C(116)-C(117)  1.433(3) 
C(117)-C(118)  1.363(3) 
C(117)-C(119)  1.499(3) 
C(118)-H(118)  0.9500 
C(119)-H(11A)  0.9800 
C(119)-H(11B)  0.9800 
C(119)-H(11C)  0.9800 
C(120)-C(121)  1.389(3) 
C(120)-C(125)  1.404(3) 
C(121)-C(122)  1.396(3) 
C(121)-H(121)  0.9500 
C(122)-C(123)  1.379(3) 
C(122)-H(122)  0.9500 
C(123)-C(124)  1.387(4) 
C(123)-H(123)  0.9500 
C(124)-C(125)  1.388(3) 
C(124)-H(124)  0.9500 
C(125)-H(125)  0.9500 
C(126)-C(127)  1.528(3) 
C(126)-H(12A)  0.9900 
C(126)-H(12B)  0.9900 
C(127)-H(12C)  0.9800 
C(127)-H(12D)  0.9800 




































































































































































































































Symmetry transformations used to generate equivalent atoms:  





Table S20.  Anisotropic displacement parameters  (Å2x 103) for P15247.  The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 19(1)  17(1) 18(1)  -4(1) 1(1)  3(1) 
C(1) 16(1)  14(1) 13(1)  2(1) 5(1)  0(1) 
N(1) 13(1)  13(1) 15(1)  -1(1) 3(1)  0(1) 
C(2) 14(1)  18(1) 11(1)  5(1) 4(1)  1(1) 
C(3) 17(1)  19(1) 16(1)  0(1) 6(1)  1(1) 
C(4) 19(1)  26(1) 15(1)  -2(1) 1(1)  0(1) 
C(5) 20(1)  29(1) 20(1)  2(1) -2(1)  5(1) 
C(6) 19(1)  23(1) 25(1)  3(1) 4(1)  5(1) 
C(7) 16(1)  19(1) 17(1)  3(1) 6(1)  2(1) 
C(8) 20(1)  16(1) 22(1)  1(1) 4(1)  4(1) 
C(9) 16(1)  15(1) 19(1)  -3(1) 4(1)  2(1) 
C(10) 15(1)  12(1) 13(1)  -1(1) 4(1)  1(1) 
N(2) 15(1)  13(1) 12(1)  -1(1) 3(1)  -1(1) 
C(11) 12(1)  16(1) 14(1)  4(1) 3(1)  3(1) 
C(12) 17(1)  17(1) 18(1)  1(1) 3(1)  0(1) 
C(13) 16(1)  20(1) 28(1)  7(1) 5(1)  1(1) 
C(14) 21(1)  27(1) 24(1)  11(1) 14(1)  5(1) 
F(1) 36(1)  35(1) 40(1)  12(1) 27(1)  1(1) 
C(15) 21(1)  25(1) 17(1)  4(1) 9(1)  7(1) 
C(16) 15(1)  19(1) 13(1)  3(1) 2(1)  5(1) 
C(17) 18(1)  18(1) 14(1)  0(1) 2(1)  4(1) 
C(19) 26(1)  25(1) 17(1)  -4(1) 3(1)  3(1) 
C(18) 14(1)  15(1) 15(1)  0(1) 1(1)  0(1) 
C(20) 17(1)  12(1) 17(1)  0(1) 7(1)  2(1) 
C(21) 16(1)  17(1) 19(1)  -1(1) 6(1)  0(1) 
C(22) 20(1)  20(1) 29(1)  -3(1) 12(1)  -2(1) 
C(23) 28(1)  18(1) 36(1)  5(1) 20(1)  2(1) 
C(24) 29(1)  24(1) 24(1)  9(1) 13(1)  8(1) 
C(25) 18(1)  21(1) 20(1)  3(1) 8(1)  5(1) 
C(26) 17(1)  12(1) 17(1)  0(1) 3(1)  2(1) 
C(27) 20(1)  15(1) 22(1)  1(1) -2(1)  2(1) 
O(101) 17(1)  19(1) 24(1)  9(1) -1(1)  -2(1) 
C(101) 15(1)  14(1) 13(1)  0(1) 5(1)  1(1) 
N(101) 12(1)  15(1) 17(1)  4(1) 2(1)  -1(1) 
C(102) 13(1)  21(1) 14(1)  -2(1) 4(1)  1(1) 
C(103) 18(1)  26(1) 15(1)  1(1) 4(1)  1(1) 
C(104) 21(1)  34(1) 17(1)  2(1) 0(1)  5(1) 




C(106) 15(1)  36(2) 28(1)  -10(1) 4(1)  -5(1) 
C(107) 17(1)  22(1) 20(1)  -6(1) 7(1)  -1(1) 
C(108) 21(1)  21(1) 26(1)  -2(1) 7(1)  -5(1) 
C(109) 22(1)  29(2) 44(2)  19(1) -3(1)  -10(1) 
C(110) 15(1)  14(1) 13(1)  2(1) 4(1)  2(1) 
N(102) 16(1)  13(1) 13(1)  2(1) 4(1)  1(1) 
C(111) 14(1)  13(1) 16(1)  -1(1) 4(1)  -3(1) 
C(112) 18(1)  14(1) 18(1)  1(1) 6(1)  -2(1) 
C(113) 17(1)  15(1) 26(1)  -2(1) 6(1)  -1(1) 
C(114) 18(1)  22(1) 23(1)  -11(1) 8(1)  -4(1) 
F(101) 32(1)  32(1) 32(1)  -10(1) 18(1)  3(1) 
C(115) 20(1)  26(1) 15(1)  -1(1) 6(1)  -6(1) 
C(116) 15(1)  18(1) 14(1)  -1(1) 2(1)  -5(1) 
C(117) 19(1)  17(1) 15(1)  1(1) 3(1)  -5(1) 
C(118) 17(1)  14(1) 17(1)  3(1) 2(1)  -1(1) 
C(119) 30(1)  24(1) 16(1)  6(1) 6(1)  -1(1) 
C(120) 12(1)  13(1) 18(1)  2(1) 2(1)  3(1) 
C(121) 17(1)  18(1) 18(1)  3(1) 3(1)  2(1) 
C(122) 20(1)  22(1) 21(1)  1(1) -1(1)  -1(1) 
C(123) 14(1)  20(1) 31(1)  2(1) 3(1)  -1(1) 
C(124) 16(1)  19(1) 27(1)  4(1) 8(1)  1(1) 
C(125) 17(1)  16(1) 20(1)  1(1) 6(1)  1(1) 
C(126) 17(1)  15(1) 17(1)  1(1) 4(1)  2(1) 





 Table S21.  Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for P15247. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(3) 4312 3349 3314 20 
H(4) 4876 2875 4280 25 
H(5) 5256 -179 4354 29 
H(6) 5079 -2821 3454 27 
H(8A) 4368 -4224 2419 23 
H(8B) 4599 -2981 1928 23 
H(9A) 4040 -1469 1308 20 
H(9B) 3815 -2589 1835 20 
H(12) 3887 4199 1065 21 
H(13) 4263 5318 298 26 
H(15) 3909 249 -1041 24 
H(19A) 3233 -4395 -601 35 
H(19B) 3549 -3408 -961 35 
H(19C) 3111 -2555 -1200 35 
H(18) 3119 -2318 526 18 
H(21) 2645 -617 931 21 
H(22) 2283 -2850 1472 27 
H(23) 2535 -3985 2677 30 
H(24) 3150 -2831 3335 29 
H(25) 3511 -572 2806 23 
H(26A) 3023 3762 1742 19 
H(26B) 3301 4541 1267 19 
H(27A) 2849 2713 237 31 
H(27B) 2697 4887 502 31 
H(27C) 2557 2642 737 31 
H(103) 4327 6971 8390 24 
H(104) 4905 6678 9336 30 
H(105) 5388 9249 9500 36 
H(106) 5314 12122 8693 32 
H(10A) 4830 12854 7150 27 
H(10B) 4693 14395 7707 27 
H(10C) 4074 13583 7206 41 
H(10D) 4208 12366 6574 41 
H(112) 3999 6669 6378 20 
H(113) 4331 4798 5665 23 
H(115) 4041 9244 4064 24 




H(11A) 3330 12330 3729 35 
H(11B) 3743 13471 4015 35 
H(11C) 3373 14429 4221 35 
H(121) 3098 8265 5335 21 
H(122) 2549 6077 5041 26 
H(123) 2249 5097 5932 27 
H(124) 2510 6241 7131 24 
H(125) 3064 8367 7435 21 
H(12A) 3475 13520 6669 20 
H(12B) 3054 12522 6562 20 
H(12C) 3251 11399 7813 31 
H(12D) 3247 13937 7722 31 
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